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Abstract 
 
Alginates are a class of natural unbranched linear polysaccharides, and consist of the 
monomers β-D-mannuronic acid and α-L-guluronic acid. The inherent physical properties, 
relative ease of modification, wide availability and good biocompatibility of alginates 
have gained a great deal of attention with regards to therapeutic applications. Heparin is a 
highly negatively charged linear glycosaminoglycan that is widely used as an 
anticoagulant. The presence of carboxyl groups and several sulfate groups gives heparin 
its negative charge, while iduronic acid moieties confer a high degree of flexibility to the 
polysaccharide by being able to assume different stable conformations. Heparin shows 
diversity in molecular weight, monomer sequence and modification pattern, resulting in a 
vast range of biological effects. When administered therapeutically, this can in cause an 
unpredictable dose response and potentially severe adverse effects in certain patients. The 
main objective of this study was to create a structural analog of heparin exhibiting a more 
regular structure and distribution, through chemical sulfation of alginate using 
chlorosulfonic acid. Other important aims were to characterize the analog in terms of 
structure, distribution and sulfation degree, and assess protein binding and anticoagulating 
properties of the sulfated alginates in comparison with heparin and the unmodified 
alginate templates.  
 
Sulfation was performed using chlorosulfonic acid in formamide on a polymannuronic 
acid (poly-M) and a polyalternating alginate with a guluronic acid fraction of FG = 0.46 
(poly-MG), introduced through enzymatic epimerization. FTIR, elemental analysis with 
HR-ICP-MS and carbon NMR were employed to detect the attached sulfate groups on the 
alginate. The average molecular weights and the mass distributions of the alginate samples 
were studied using SEC-MALLS. Elemental analysis was used to estimate the sulfation 
degrees of the alginates, and 
13
C NMR was employed to study substitution patterns, 
provide additional DS estimates and assess sample purity. The protein binding properties 
of the sulfated alginates were evaluated by studying their ability to release hepatocyte 
growth factor and osteoprotegerin bound to myeloma cells. Anticoagulating properties 
were studied by measuring prolongation of plasma coagulation time as a result of sulfated 
alginate supplementation.   
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The alginates were successfully sulfated and exhibited different degrees of sulfation 
obtained by varying the chlorosulfonic acid concentration used (1 - 10 %), as estimated by 
elemental analysis. The poly-MG alginate showed increased solubility during the sulfation 
reaction, resulting in a higher estimated DS at lower chlorosulfonic acid concentrations 
compared with poly-M. No apparent degradation of the alginates as a result of the 
sulfation was observed, although preliminary acid hydrolysis resulted in a molecular 
weight disparity between poly-M and poly-MG samples. Analysis of carbon NMR spectra 
allowed characterization of novel peaks and secondary DS estimations for the sulfated 
poly-M samples, while the complexity of the sulfated poly-MG spectra prevented 
confident characterization of the structures. Sulfation resulted in a profound improvement 
of the protein binding properties of the alginates, and showed prolongation of the plasma 
coagulation time at high treatment concentrations.  
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Abstract - Norwegian 
 
Alginater er en gruppe uforgrenede, lineære polysakkarider bygd opp av monomerene  β-
D-mannuronsyre og α-L-guluronsyre. De iboende fysiske egenskapene, 
modifikasjonsmulighetene, store tilgjengeligheten og den høye biokompatibiliteten til 
alginater har tiltrukket stor oppmerksomhet med henhold til terapeutiske applikasjoner. 
Heparin er et høyt negativt ladd molekyl i glykosaminoglykan-familien og er omfattende 
brukt som et antikoagulerende legemiddel. Karboksylgrupper og flere sulfatgrupper på 
monomerene gir heparin dets negative ladning, mens iduronsyre-monomerer tilfører 
molekylkjeden fleksibilitet ved å kunne innta ulike stabile konformasjoner. Heparin 
innehar en høy diversitet med henhold til molekylvekt, monomersekvens og 
modifikasjonsmønster, som resulterer i et bredt spekter av biologiske effekter som kan 
videre medføre en uforutsigbar respons til en gitt dose, samt potensielt alvorlige 
bivirkninger. Hovedhensikten med dette prosjektet var å lage en strukturell analog til 
heparin med en mer regelmessig struktur, gjennom kjemisk sulfatering av alginat ved bruk 
av klorsulfonsyre. Andre viktige mål var å karakterisere analogen med henhold til 
struktur, distribusjon og sulfateringsgrad, samt undersøke proteinbindende og 
antikoagulerende egenskaper i de sulfaterte alginatene sammenlignet med heparin og 
umodifiserte alginater. 
 
Sulfatering ble utført ved bruk av klorsulfonsyre i formamid på en polymannuronsyre 
(poly-M) og en polyalternerende alginat med en guluronsyrefraksjon på FG = 0.46 (poly-
MG), introdusert gjennom enzymatisk epimerisering. FTIR, elementanalyse med HR-ICP-
MS og karbon-NMR ble gjennomført for å detektere sulfatgruppene på alginatet. De 
gjennomsnittlige molekylvektene og massedistribusjonene til de ulike alginatprøvene ble 
undersøkt ved bruk av SEC-MALLS. Elementanalyse ble videre brukt til å estimere 
sulfateringsgraden (DS) til alginatene, og 
13
C-NMR ble brukt til å undersøke studere 
substitusjonsmønster, gi et sekundærestimat av DS og bestemme prøvenes renhet. 
Proteinbindende egenskaper i de sulfaterte alginatene ble undersøkt ved å studere deres 
evne til å binde og frigjøre hepatocytt-vekstfaktor og osteoprotegerin fra overflaten av 
myelomceller. Antikoagulerende egenskaper ble studert ved å måle forlengelse av 
koagulasjonstiden til blodplasma som resultat av tilsatte sulfaterte alginater.     
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Alginatene ble sulfatert og viste ulike grader av sulfatering som resultat av varierende 
konsentrasjon av klorsulfonsyre brukt (1 - 10 %), estimert gjennom elementanalyse. Poly-
MG alginatene viste høyere løselighet under sulfateringsreaksjonen, som resulterte i en 
høyere estimert DS ved lavere konsentrasjon av klorsulfonsyre, sammenlignet med poly-
M. Det ble ikke observert noen betydelig degradering av alginatene som resultat av 
sulfateringen, men syrehydrolyse av alginatene i forkant av sulfateringen resulterte i ulik 
gjennomsnittlig molekylvekt for poly-M- og poly-MG-alginatene. Analyse av 
13
C-NMR 
spektre resulterte i en karakterisering av nye signaler oppstått fra sulfatering, samt en DS-
estimasjon for de sulfaterte poly-M-alginatene, mens kompleksiteten i poly-MG-spektrene 
hindret tilsvarende karakterisering av alginatstrukturene med sikkerhet. Sulfatering av 
alginatene resulterte i en markant økning i proteinbinding, og viste ved høye 
konsentrasjoner en målbar forlengelse av koagulasjonstiden. 
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Symbols and Abbreviations 
 
 
AT 
 
Antithrombin III 
dn/dc 
 
Refractive index 
DP 
 
Degree of polymerization 
DS 
 
Degree of sulfation 
FG 
 
Guluronic acid monad fraction 
FTIR 
 
Fourier transform infrared spectroscopy 
G 
 
α-L-guluronic acid 
GAG 
 
Glycosaminoglycan 
GlcA 
 
β-D-glucuronic acid 
GlcN 
 
β-D-glucosamine 
HCII 
 
Heparin cofactor II 
HGF 
 
Hepatocyte growth factor 
HIT 
 
Heparin-induced thrombocytopenia 
HR-ICP-MS 
 
High resolution inductively coupled plasma mass spectroscopy 
HS 
 
Heparan sulfate 
IdoA 
 
α-L-iduronic acid 
LMWH 
 
Low-molecular weight heparin 
M 
 
β-D-mannuronic acid 
MFI 
 
Mean fluorescence intensity 
Mn 
 
Molecular number average 
Mw 
 
Molecular weight average 
NAG 
 
N-acetylglucosamine 
NHP 
 
Normal human plasma 
NMR 
 
Nuclear magnetic resonance 
OPG 
 
Osteoprotegerin 
RPMI 
 
Roswell park memorial institute (myeloma cell line) 
SEC-MALLS 
 
Size exclusion chromatography - multi-angle laser light scattering 
S-M 
 
Sulfated polymannuronic acid 
S-MG 
 
Sulfated polyalternating alginate of MG-blocks 
UFH 
 
Unfractionated heparin 
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1 Introduction 
 
1.1 Background 
 
Heparin has been widely used as an anticoagulant since the discovery of its antithrombotic 
properties, and is used today primarily during surgery and as a prophylactic to treat a 
number of cardiovascular disorders. Although often fractionated and chemically modified, 
commercial heparin is still of mammalian origin, as the complexity and diversity of the 
molecule limits synthetic production to short oligomers (Bhaskar, Sterner et al. 2012). The 
inherent heterogeneity is correlated to the many observed physiological effects of heparin, 
complicating therapeutic use to effectively treat individual disorders while minimizing 
adverse effect. Finding alternative anticoagulating drugs with more limited number of 
interaction targets could reduce the incidences of excessive bleeding and immune 
reactions, and possibly bypass cases of heparin resistance. There have also been 
incidences with contamination of heparin batches (Li, Suwan et al. 2009), and the porcine 
origin of most commercial heparin also raises an issue when treating devout Muslim or 
Jewish patients. Although the heparin undergoes extensive chemical treatment during 
purification and is administered in relatively small amounts through injection rather than 
consumption, some Muslims and Jews still consider the drug forbidden unless used in life-
threatening situations, where heparin is seldom used.  
 
Alginate is a good candidate for creating a functional analog to heparin primarily due to 
its wide availability, good biocompatibility, structural similarity and several modification 
possibilities. Alginate is abundant in seaweeds and can be produced by bacteria in 
reactors. The relative ease of modifying the alginate structure enables creation of more 
specific polymeric drugs while retaining the biocompatibility of a natural compound. 
Genetically modified bacterial cultures can produce a pure polymannuronic acid template, 
allowing tailoring of the polymer using C5 epimerase enzymes in order to obtain specific 
sequence patterns. Structural similarity to heparin and an equally high charge density can 
be attained, as alginate monomers each have an inherent carboxyl group and two free 
hydroxyl groups susceptible to sulfation. Extensive research has elucidated new structure-
function relationships in heparin, enabling the construction of analogous modification 
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patterns from an alginate template. An important difference between heparin and an 
alginate-based analog is that the latter can be modified to have a regularity in size, 
sequence and potentially sulfation pattern not seen in heparin. This is assumed to provide 
a more predictable drug response, and the sulfated alginates may have a more narrow 
range of physiological effects compared to the structurally disperse heparin.  
 
 
1.2 Alginate 
 
1.2.1 Structure and Physical Properties 
 
Alginates are a group of unbranched polysaccharides primarily found in brown seaweeds, 
but is also produced by certain bacterial species, such as Pseudomonas aeruginosa and 
Azotobacter vinelandii. Bacterial alginates are commonly secreted extracellularly and 
used in biofilm formation or cyst generation (Rehm and Valla 1997), while in seaweeds 
the alginate serves as a structural component. Alginates are linear co-polymers consisting 
of the monomers β-D-mannuronic acid (M) and α-L-guluronic acid (G) (Figure 1). 
Naturally occurring alginates do not have regular repeating units, and the M- and G-units 
are either alternating or arranged in homopolymeric blocks of various lengths. Monomer 
distribution and block lengths are important characteristics of alginates as they have a 
significant impact on the physical properties. 
 
 
Figure 1: Constituent monomers of alginate. 
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The conformational difference between the monomers results in either diequatorial (M-
M), equatorial-axial (M-G, G-M) or diaxial (G-G) bonding (Figure 2), leading to varying 
degrees of rotation and thus flexibility along the alginate chain. The diaxial bonds 
between adjacent G-monomers form cavities in the molecular structure of the alginate, 
allowing cooperative binding of divalent cations (e.g. Ca
2+
, Ba
2+
 and Sr
2+
). The ions serve 
as cross-linkers and bind other alginate chains, ultimately forming a hydrated gel network 
(Smidsrød and Skjåk-Bræk 1990).   
 
Figure 2: Polymeric structure of alginate showing glycosidic bond orientations between monomers β-
D-mannuronic acid (M) and α-L-guluronic acid (G) 
 
Alginates are polyelectrolytes, and are the only natural occurring polymers containing a 
carboxyl group on each constituent monomer  (Ikeda, Takemura et al. 2000). The pK 
value of alginate is approximately 3.6 (Simsek-Ege, Bond et al. 2003), meaning that the 
carboxyl group is deprotonated at neutral pH, giving alginates an evenly distributed net 
negative charge. The flexibility of the alginate chains increases in the order GG<MM<MG 
(Smidsrød and Skjåk-Bræk 1990), as the axial-equatorial bonding confers less steric 
hindrance and thus an increased range of rotation compared to diequatorial linkage 
between two M monomers (Smidsrød 1973).  
  
Molecular weight of alginates is an important factor in gel formation, affecting properties 
such as mechanical strength, porosity and swelling. It is also relevant for the application 
of alginate chains in solution, as high molecular weight alginates can significantly 
increase the viscosity of concentrated solutions. In a solution containing live cells, an 
increase in viscosity leads to higher mixing requirements to maintain sufficient mass 
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transport of gases and nutrients (Doran 1995). Shear forces from the mixing or injection of 
such viscous solutions may compromise proteins and cells present, which is highly 
relevant for the application of dissolved alginate in biological systems (Kong, Smith et al. 
2003). 
 
 
1.2.2 C5 Epimerization 
 
Epimerization is a process whereby a diastereomer of a molecule is formed through re-
configuration of a single stereogenic center. In nature epimerization of carbohydrates is 
catalyzed by enzymes known as epimerases and, in the case of polysaccharides, usually 
occurs prior to polymerization. However, certain epimerases can convert monomers post-
polymerization without compromising the polymer backbone. Examples of such reactions 
are C5 epimerizations of D-mannuronic acid into L-guluronic acid in alginates, and D-
glucuronic acid into L-iduronic acid during heparin and heparan sulfate (HS) synthesis 
(Valla, Li et al. 2001). During the epimerization process in alginates, carbon 5 of D-
mannuronic acid is re-configured, forming the epimer L-guluronic acid. The most stable 
conformation for the M units is the 
4
C1  chair, but during epimerization the hexapyranose 
ring will assume the inverted 
1
C4 chair conformation. The switch alters the bond 
orientations and thus the overall conformation of the alginate chain, making epimerization 
a useful tool to alter the physical properties of alginate. Mutant bacterial strains can be 
utilized to produce pure polymannuronic acid (Gimmestad, Sletta et al. 2003), and 
different epimerases can be used to tailor the polymer, introducing specific sequence 
patterns in vitro. 
 
In algae and bacteria, L-guluronic acid monomers of alginate are not synthesized de novo, 
but introduced through epimerization following chain assembly. Alginate-producing 
species are thus able to determine the physical properties of the polymer through 
controlled regulation and expression of various forms of the C5 epimerases. As alginate is 
an important structural component of the algae cell wall and intercellular spaces, as well 
as in bacterial biofilms and cysts, regulation of epimerization allows efficient adaptation 
to various environments. For instance, the commercially important seaweed Laminaria 
hyperborea has a relatively high content of G blocks in the stipe and outer cortex, while 
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the leaf has a lower content of G units that are primarily interspaced between M 
monomers (Smidsrød and Skjåk-Bræk 1990). The ability of continuous G blocks to bind 
Ca
2+
 and form gels provides the mechanical strength and rigidity required to withstand 
environmental forces on the seaweeds.  
 
Bacterial alginates are excreted and epimerized extracellularly, where they participate in 
the formation of protective layers such as viscous fluids or solid-like cysts. Alginate-
producing bacteria have been shown to express a variety of calcium-dependent C5 
epimerases and have been thoroughly studied for commercial application of the 
epimerases (Ertesvåg, Høidal et al. 1999), and additionally for their role in the progression 
of cystic fibrosis (Jain, Franklin et al. 2003). Alginate from studied species of the 
Pseudomonas genus does not exhibit G blocks and each G monomer is interspaced by at 
least one M (Skjåk-Bræk, Grasdalen et al. 1986). Epimerases from different Azotobacter 
species, however, introduce G and MG blocks in specific patterns. Of particular interest is 
the epimerase AlgE4, which exclusively introduces an alternating MG sequence along the 
alginate chain without G block formation (Ertesvåg, Høidal et al. 1999). Mannuronic acid 
monomers of bacteria-derived alginates have been found to exhibit various degrees of 
acetylation at the hydroxyl groups on carbons 2 and 3 (Skjåk-Bræk, Grasdalen et al. 
1986). The lack of acetyl groups on guluronic acid monomers indicates that the added 
bulkiness on acetylated M units prevents epimerization by the enzymes, and that 
acetylation is an important factor for regulating alginate sequence in bacteria (Valla, Li et 
al. 2001).   
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1.2.3 Covalent Modification of Alginates 
 
The alginate monomers are susceptible to a number of chemical modification reactions, 
enabling alteration of the polysaccharide’s inherent properties, introduction of new 
properties and facilitation of additional intermolecular interactions. Together with the 
epimerization techniques utilized to manipulate monomer sequence, chemical 
modification of alginate can offer a vast variety of novel alginate derivatives.  
 
Targeting the carboxyl group present on all alginate monomers, a common modification 
strategy employs carbodiimide molecules which can activate and expose the carboxylic 
group to a nucleophilic attack (Cathell, Szewczyk et al. 2010). As cells do not commonly 
attach to alginate due to its hydrophilic nature, previous work has been done to attach 
Arginine-Glycine-Aspartic Acid (RGD)-containing peptides to the carboxyl group of 
alginates to enable interaction and cell anchorage in immobilization and encapsulation 
systems. Here, the terminal amine nitrogen of the peptide functions as the nucleophile and 
forms an amide bond to alginate (Rowley, Madlambayan et al. 1999). The same strategy 
can be utilized to cross-link alginate with other sugars, as demonstrated by Donati and 
coworkers (2003) with the coupling of the carboxyl groups of the alginate monomers to 
the anomeric carbon of galactose via an amide bond (Donati, Vetere et al. 2003). 
 
Alginate can be extensively modified at the free hydroxyl groups on C2 and C3, primarily 
through addition of small chemical groups or cross-linking reactions via ether or ester 
bonds. For instance, esterification with propyleneoxide forms propylene glycol alginate 
(PGA), a widely used derivative in the food industry (Draget, Skjåk-Bræk et al. 1997). 
Esterification to longer alkyl chains can lower the water solubility of alginate and promote 
hydrophobic interactions (Rastello De Boisseson, Leonard et al. 2004). Sulfate groups can 
be added to the available hydroxyl groups in order to improve blood compatibility and 
promote anticoagulating properties, similarly to heparin and heparan sulfate (HS). 
Sulfated alginates can easily be attained through reacting dried alginate with 
chlorosulfonic acid (ClSO3H) in formamide (Huang, Du et al. 2003). Using an alternative 
strategy, sodium alginate is converted to a tertiary amine salt followed by sulfation using 
carbodiimide and sulfuric acid (H2SO4) (Freeman, Kedem et al. 2008). Both reactions are 
performed under strong acidic conditions, which can cause precipitation of the alginate 
and some degree of depolymerization in high molecular weight chains. A more recent 
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strategy involves synthesizing a sulfating agent without the use of strong acids, and has 
been successfully employed to sulfate alginate, chitosan and pectin (Fan, Jiang et al. 
2011), (Fan, Wu et al. 2012), (Fan, Gao et al. 2012). The sulfating agent (N(SO3Na)3) was 
prepared from sodium bisulfate and sodium nitrate in an aqueous medium and allowed 
sulfation without any measureable degradation of the polysaccharides. 
 
It is also possible to modify the hexose backbone of the alginate through a partial 
oxidation reaction using periodate, resulting in ring opening between C2 and C3 (Scott 
and Harbinson 1969). Periodate oxidation of 5 % of the uronic acid monomers retains 
most desired properties of the alginate such as gelling (Gomez, Rinaudo et al. 2007), 
while conferring increased flexibility and solubility, and decreased viscosity in solution. 
In contrast to non-oxidized alginate, the open-chain derivative is also susceptible to 
backbone degradation in an aqueous media under physiological conditions (Bouhadir, Lee 
et al. 2001). 
 
The range and extent of possible modifications have been limited by a lack of solubility of 
alginates in organic solvents. Certain modification reactions in aqueous solutions also 
have clear disadvantages due to the low stability of alginate in very acidic, basic or 
reductive environments (Pawar and Edgar 2012). Complete organic solubility has, 
however, been achieved using a tetrabutylammonium (TBA) salt of alginic acid in a polar 
aprotic solvent of tetrabutylammonium fluoride (TBAF) with dimethyl sulfoxide (DMSO) 
(Pawar and Edgar 2011). Another challenge is achieving selectivity when modifying the 
hydroxyl groups of alginate. Due to the similar chemical environments of C2 and C3, 
most reactions affect both targets at equal frequencies (Pawar and Edgar 2012). However, 
conformational variations arising from different bond orientations between the M and G 
monomers may impose steric hindrance towards addition of bulky groups, causing 
favoring of one hydroxyl group over the other.  
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1.2.4 Therapeutic Use of Alginates 
 
The gel-forming ability, biocompatibility, physical properties and vast modification 
possibilities make alginates suitable in a number of therapeutic applications. Gel-forming 
alginates have widespread use in hydrogel-based wound dressings and can function as 
carriers in drug delivery systems. Furthermore, chemically modified alginate derivatives 
can mimic the actions of physiologically important polysaccharides or assume new 
beneficial functions. 
Hydrogel-based wound dressings are particularly useful in treating burn injuries. The most 
important desired properties of burn dressings are fluid absorption, in order to collect 
exudates and maintain a moist environment for effective reepithelialization and healing, 
and to serve as a barrier against microbial infections (Quinn, Courtney et al. 1985). 
Hydrogels are transparent, can absorb a large amount of fluid and can be shaped in situ to 
properly fit the wound. Additionally, substances such as antimicrobial drugs, cytokines 
and growth factors can be embedded in the gel matrix to prevent infection and aid 
regeneration of tissue (Balakrishnan, Mohanty et al. 2005). Alginate gels can also be used 
as an excipient in drug delivery systems due to their gentle gelling conditions that don’t 
compromise the drug carried (Augst, Kong et al. 2006). Cells may also be encapsulated in 
alginate gel beads for use in bioreactors, and have also been proposed to function as a 
barrier against the immune system in foreign tissue transplants, while still allowing gas 
and nutrient exchange with the environment (Smidsrød and Skjåk-Bræk 1990).  
 
Sulfated alginates have been shown in the laboratory to exhibit potent blood regulating 
properties, having structural and functional similarities to the anticoagulating 
glycosaminoglycan heparin. The structural flexibility of alginates can be increased 
through targeted epimerization, while sulfate groups provide additional negative charges 
to the anionic alginate, allowing charge-dependent binding to a number of physiologically 
important proteins. Sulfated alginates have previously been shown to increase blood 
clotting time (Huang, Du et al. 2003), (Fan, Jiang et al. 2011), probably due to direct or 
indirect interaction with factors in the coagulation cascade. Sulfated alginates can also 
bind growth factors such as fibroblast growth factors (FGF) (Freeman, Kedem et al. 
2008), and can thus affect angiogenesis when administered intravenously. In a different 
study, Hu and colleagues (2004) observed antitumor activity when administering 
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oligosaccharide derivatives of sulfated alginates to mice. While no direct cytotoxic effects 
were seen, the oligomers were suggested to have an indirect effect through stimulation of 
the host-mediated immune system, and could potentially be applied as an adjuvant in 
cancer therapy (Hu, Jiang et al. 2004).  
 
Alginate as a food additive is generally recognized as safe (GRAS) by the Food and Drug 
Administration (FDA). It has been widely used as an additive due to its ability to hold 
water, form thermally stable gels and stabilize phases in a number of food products 
(Glicksman 1987). Alginate itself is not toxic to cells and has negligible immunogenicity, 
but can carry contaminants from the source organism or from the extraction process. 
Highly immunogenic lipopolysaccharide (LPS) may be associated with the alginate from 
bacterial isolates (Breger, Lyle et al. 2009), while seaweed extracts contain traces of toxic 
polyphenols and require purification (Smidsrød and Skjåk-Bræk 1990). Regardless of 
purity, alginate gel implants used for drug- or cell encapsulation may still be recognized as 
foreign bodies, resulting in an inflammatory response with fibrous capsule formation 
around the implants and impediment of the mass transport (Klock, Pfeffermann et al. 
1997).  
 
Implanted alginate gels dissolve following sequestration of the cross-linking cations, 
while complete clearance of free alginate chains from the circulation requires renal 
excretion. Chains with a molecular weight under 48 kDa/mol are readily excreted into the 
urine, while the larger fraction remains in the circulation (Alshamkhani and Duncan 
1995). Mammals are unable to degrade the alginates due to a lack of the enzyme alginase. 
However, partial oxidation through periodate treatment renders the alginate susceptible to 
hydrolysis in a physiological environment, allowing degradation into lower-weight chains 
(Lee and Mooney 2012). 
 
 
  
10 
 
1.3 Heparin 
 
1.3.1 Heparin Structure and Distribution 
 
Heparin is a linear polysaccharide in the glycosaminoglycan (GAG) family. The relatively 
high density of sulfate groups makes it the most negatively charged biological polymer to 
be characterized (Jones, Beni et al. 2011). Heparan sulfate (HS) is a GAG similar to 
heparin in backbone structure, but is less sulfated and contains fewer α-L-iduronic acid 
(IdoA) residues (Yu and Chen 2007). While heparin is released as soluble chains through 
exocytosis, HS remains bound to the cell surface via a transmembrane linker protein. 
Heparin can be extracted from mast cells of various animal mucosa, but commercial-scale 
production is today primarily from porcine intestine (Bhaskar, Sterner et al. 2012). The 
two-dimensional structure of heparin consists of repeating disaccharides of β-D-
glucosamine (GlcN) and an uronic acid, which may be β-D-glucuronic acid (GlcA) or α-L-
iduronic acid (IdoA). The constituent monomers exhibit a varying substitution pattern, 
introduced during biosynthesis of heparin and HS. The ammonium group of the GlcN 
moiety may be N-sulfated, acetylated or unmodified (NH3
+
), and sulfate groups can be 
added to 3-O and 6-O positions in varying patterns. The uronic acids may be either 
unmodified or 2-O sulfated (Figure 3) (Jones, Beni et al. 2011). 
 
Figure 3: Constituent monomers of heparin: (A) Uronic acids β-D-glucuronic acid (β-D-GlcA) and α-L-
iduronic acid (α-L-IdoA), unsubstituted or with 2O-sulfation (2S). (B) Amino sugars β-D-glucosamine 
(β-D-GlcN), unsubstituted, N-acetylated or N-sulfated (R = H or SO3
-
). 
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Therapeutic heparin can be divided into two main classes based on mean molecular 
weight: unfractioned heparin (UFH) and low-molecular weight heparin (LMWH). UFH 
has a weight distribution of 3 - 30 kDa/mol with a mean of 15 kDa (Hirsh, Anand et al. 
2001), while the weight range of LMWH is 1 - 10 kDa with a mean between 4 and 5 
kDa/mol (Hirsh 1998). Additionally, some recently derived drugs are based on an ultra 
low-molecular weight heparin (ULMWH) oligosaccharide, with high selectivity for 
specific interactions in the coagulation cascade (Bhaskar, Sterner et al. 2012), (Petitou and 
van Boeckel 2004).  
 
 
1.3.2 Physical Properties of Heparin 
 
The L-iduronic acid component of heparin gives heparin its high inherent flexibility, as the 
ring can assume three different conformations: chairs 
1
C4 and 
4
C1, and the skew-boat 
2
S0 
(Figure 4) (Sasisekharan and Venkataraman 2000). While the 
2
S0 has been shown to be the 
active conformation in important interactions such as antithrombin III (AT) binding, it is 
likely that the molecular environment (e.g. neighboring monomers and interaction targets) 
as well as chemical factors such as salt concentration and pH can affect the current 
conformation of IdoA (Petitou and van Boeckel 2004), (Ernst, Venkataraman et al. 1998). 
This flexibility, in addition to the sequential heterogeneity of the polysaccharide, is 
assumed to contribute to the observed versatility of heparin in regulatory interactions 
(Rees, Morris et al. 1985). 
 
 
Figure 4: Structural conformations of α-L-iduronic acid in heparin and heparan sulfate. 
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1.3.3 Biosynthesis and Post-Glycosylational Modification 
 
Heparan sulfate (HS) is expressed in all types of cells as a constituent of the extracellular 
matrix, while heparin is synthesized exclusively in mast cells (Parra, Veraldi et al. 2012). 
Both GAGs are produced and modified in the Golgi apparatus. Starting chains of four 
monosaccharides each are attached to a core protein and disaccharides of GlcA and N-
acetylglucosamine (NAG) are subsequently added to the growing chains by 
glycosyltransferase enzymes (Sasisekharan and Venkataraman 2000). As with the alginate 
presented above, the synthesis of heparin and HS is not template driven, resulting in 
chains of highly variant lengths, consisting of 10-200 disaccharide units (Orgueira, 
Bartolozzi et al. 2003). The nascent chains of alternating GlcA and NAG are then 
modified in a series of reactions, resulting in biologically active heparin and heparan 
sulfate. For heparin, the peptide core of the proteoglycan intermediate is cleaved and the 
polysaccharide is endocytosed into secretory granules within the mast cells (Conrad 
1998).  
 
The enzymatic modifications occur either concurrently or in a sequence of independent 
steps (Sasisekharan and Venkataraman 2000). Most of the NAG monomers added during 
synthesis are deacetylated, forming a substrate for N-sulfation. Furthermore, N-sulfation is 
a prerequisite for subsequent C5 epimerization of D-glucuronic acid into L-iduronic acid, 
as well as O-sulfation (Jacobsson, Riesenfeld et al. 1985). The major sites for O-sulfation 
are C6 on the amino sugar residues (GlcNAc and GlcNSO3H) and C2 on IdoA. Less 
frequent sulfation occurs at C3 of GlcNSO3H and at C2 of the non-epimerized GlcA 
moieties (Kusche and Lindahl 1990). Enzymes involved in the biosynthesis and 
modification of GAGs are known to have several tissue-specific isotypes, as shown for 
sulfotransferases by Habuchi and coworkers (Habuchi 2000). Different isoforms 
commonly have unique substrate specificities and most modification reactions are 
incomplete, resulting in varying patterns and extents of heparin modifications (Jacobsson, 
Riesenfeld et al. 1985).  
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1.3.4 Anticoagulating Action and other Functions  
 
Although heparin is used mainly as an anticoagulant to treat various cardiovascular 
disorders, the complexity and disparity of the molecule implicates it in other known, and 
probably several unknown, biological interactions.  
 
During the coagulation cascade, the extrinsic and intrinsic pathways coalesce in a 
common pathway with the conversion of factor X to its active form, Xa. Factor Xa cleaves 
prothrombin, forming the active serine protease thrombin which ultimately produces and 
stabilizes the insoluble fibrin clot (Triplett 2000). Heparin binds the plasma cofactor 
antithrombin III (AT) through a specific pentasaccharide sequence (Figure 5) forming a 
complex and accelerating the action of AT as a coagulation factor inhibitor.  
 
 
Figure 5: The antithrombin III-binding pentasaccharide sequence in heparin (R1 = acetyl or SO3
-
, R2 
= SO3
-
 or H). The outlined sulfate group on GlcNS3S(6S) is considered essential to AT binding. 
Adapted from (Chen and Liu 2005). 
 
While thrombin and factor Xa are the most sensitive targets (Hirsh and Raschke 2004), the 
heparin/AT-complex is also involved in the neutralization of several other factors such as 
factor IXa (Wiebe, Stafford et al. 2003) and tissue factor-bound VIIa (Lormeau, Herault et 
al. 1996). While associated with AT, heparin binds thrombin in a charge-dependent 
manner requiring at least 18 monosaccharides in the chain, increasing in effectiveness 
with chain length (Hirsh and Raschke 2004). On the other hand, Factor Xa inhibition 
appears to require only the pentasaccharide sequence in heparin associating with AT 
(Casu, Oreste et al. 1981), and is therefore the most prominent effect in low-molecular 
weight fractions of heparin.   
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Two additional anticoagulating effects of heparin are described, which function 
independently of AT and thus do not require the specific pentasaccharide sequence. The 
first involves non-specific binding and complex formation of heparin with heparin 
cofactor II (HCII), followed by thrombin inhibition by the complex. Although the 
activation mechanisms of HCII are similar to those for AT, the interaction is non-specific 
and depends on the charge and molecular weight of heparin. In contrast to AT, active 
HCII is capable of inhibiting fibrin-bound thrombin by using an alternative binding site 
(Huntington and Baglin 2003). HCII activation by heparin has been demonstrated with a 
minimal chain length of 13 monosaccharides, and the resulting thrombin inactivation is 
increased 2000-fold when doubling the heparin molecular weight (Okeeffe, Baglin et al. 
2004). However, the lacking specificity of the heparin-HCII interaction results in a 
binding affinity approximately 1000 times lower than that for heparin and AT (Huntington 
and Baglin 2003). The second AT-independent anticoagulating function of heparin 
involves charge-dependent binding to factor IXa, which in turn blocks factor Xa 
generation (Weitz, Young et al. 1999). Similarly to HCII binding, the interaction lacks 
specificity and high concentrations of heparin are required to achieve an appreciable 
therapeutic effect (Hirsh and Raschke 2004). 
 
Heparin also affects coagulation through platelet interactions. An indirect anticoagulating 
effect is inhibition of thrombin by the AT/heparin complex, thus reducing thrombin-
induced platelet aggregation (De Candia, De Cristofaro et al. 1999). Heparin can also bind 
platelets directly through integrins on the platelet surface. High-molecular weight heparin 
chains appear to accommodate sufficient binding sites for both AT and platelets, while for 
low-molecular weight heparin, subfractions with low affinity for AT predominate in 
platelet binding (Salzman, Rosenberg et al. 1980). Although the response may vary 
depending on experimental conditions and the presence of interfering factors, heparin 
binding to platelets generally induces increased platelet responsiveness and activation 
(Gao, Boylan et al. 2011), despite the inhibition of thrombin-induced platelet activation 
mentioned above. Platelet aggregation may complicate the heparin treatment by opposing 
the anticoagulating effects and possibly contributing to non-beneficial thrombosis. 
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Heparin and heparan sulfate have been shown to interact with and possibly influence the 
infectivity of certain animal viruses. Envelope proteins of dengue virus and herpes 
simplex virus bind highly sulfated motifs on cell surface HS chains, which is assumed to 
be a requirement for cell entry. Heparin can reversibly bind the same envelope proteins, 
inhibiting cell attachment of the viruses and reducing the infectivity of the viruses (Chen, 
Maguire et al. 1997), (Shukla, Liu et al. 1999), (Nahmias and Kibrick 1964).  
 
Heparin and HS are assumed to have an active regulatory role in cell proliferation, 
through the binding and stabilization of growth factors such as fibroblast growth factor 2 
(FGF-2) (Forsten, Fannon et al. 2000). Heparin also binds to the cytokine hepatocyte 
growth factor (HGF) with high affinity, and can release the protein bound to heparan 
sulfate on the cell surface and extracellular matrix (Seidel, Hjorth-Hansen et al. 1999), as 
well as from the HGF receptor c-met expressed on myeloma cells (Børset, Hjorth Hansen 
et al. 1996).   
Several factors in the clotting and fibrinolytic pathways, including aforementioned 
antithrombin III, have been proposed to also have important roles in angiogenesis 
(O'Reilly, Pirie-Shepherd et al. 1999). The direct and indirect interactions of heparin with 
these factors are thus likely to affect the formation of new blood vessels. In fact, low-
molecular weight heparin fractions have been demonstrated to have an anti-proliferative 
effect on endothelial cells in a manner both dependent on chain length and specific 
monomer modifications (Khorana, Sahni et al. 2003). The apparent antiangiogenic effects 
and growth factor-modulating properties have led to a lot of research on low-molecular 
weight heparin as an adjuvant in cancer therapy, and have in several cases been suggested 
to counteract tumor growth and metastasis (Castelli, Porro et al. 2004), (Kragh, Binderup 
et al. 2005). However, a recent study showed that the overall survival rate in several 
common cancer types is not improved by LMWH treatment, and that the beneficial effects 
of heparin in cancer treatment thus remain controversial (van Doormaal, Di Nisio et al. 
2011).  
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1.3.5 Heparin Limitations 
 
Heparin fractions with a wide distribution regarding size, sequence and modification 
pattern can have an equally wide range of pharmacodynamic properties, potentially 
causing complications when treating individual disorders. As described below, there are 
also pharmacokinetic obstacles arising when treating a patient with heparin, where some 
of these limitations can be overcome by utilizing low-molecular weight fractions 
(LMWH).  
 
Several of the pharmacokinetic limitations of unfractionated heparin as an optimal 
anticoagulant stem from charged-dependent non-specific binding to proteins and cell 
surfaces (Hirsh, Anand et al. 2001). Certain plasma components, as described with the 
abundant glycoprotein vitronectin (Preissner and Muller-Berghaus 1987), can bind and 
sequester heparin as well as low weight derivatives, resulting in reduced bioavailability. 
Molecular weight also affects the clearance rate of heparin from the circulation. Longer 
chains are cleared more rapidly, resulting in accumulation and prolonged action of low-
weight chains primarily inhibiting factor Xa, with minor effects on thrombin (Hirsh and 
Raschke 2004). Additionally, binding to macrophage and endothelial cell surfaces can 
facilitate increased clearance of heparin (Hirsh, Anand et al. 2001). The shorter chain 
length of LMWHs causes less efficient protein- and cell surface binding, resulting in 
increased bioavailability following administration, as well as prolonged action (Hirsh 
1998). The extent of these pharmacokinetic disadvantages may vary between individual 
patients, resulting in a less predictive response to a fixed dose of heparin. As previously 
mentioned, heparin complex formation with AT requires a specific pentasaccharide 
sequence which is present in approximately one third of isolated heparin molecules. 
Consequently, two thirds of the administered heparin do not bind AT and have low 
anticoagulating abilities, independent of weight fractioning (Lam, Silbert et al. 1976). 
 
An important and relatively common condition is heparin resistance, where the patient 
shows reduced responsiveness to heparin and requires a significantly larger dose to obtain 
a therapeutic effect. The diminished response can be ascribed to several pharmacokinetic 
mechanisms affecting the bioavailability of heparin, but is in most clinical scenarios 
associated with an antithrombin III deficiency (Bar-Yosef, Cozart et al. 2007). AT 
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deficiency can be a genetic trait, but low AT levels are more commonly caused by 
prolonged exposure to intravenous heparin (Marciniak and Gockerman 1977). Heparin is 
widely used during surgery to counter anticoagulation triggered by endothelial damage. 
Patients undergoing cardiac surgery commonly receive heparin preoperatively, which can 
cause heparin resistance through AT depletion, limiting the action of heparin administered 
during surgery (Bar-Yosef, Cozart et al. 2007). The effect can in part be alleviated by 
supplementation of AT through fresh frozen plasma (Sabbagh, Chung et al. 1984) or by 
increasing the dose of heparin, although the latter alternative may lead to adverse 
complications such as increased bleeding. To avoid hypotension and bradycardia, cases of 
excessive bleeding are normally treated through intravenous injection of a neutralizing 
heparin antagonist, such as protamine (Hirsh and Raschke 2004).  
 
Heparin has in some cases been shown to contribute to osteoporosis by binding and 
inhibiting the cytokine osteoprotegerin (OPG). OPG functions as an inhibitor of the NFκB 
ligand RANKL, which is secreted by osteoblasts to limit the activity of osteoclasts. 
Inhibition of OPG by heparin can thus result in osteoclast-induced bone resorption (Irie, 
Takami et al. 2007). The extent of osteoclast stimulation has been shown to be highly 
dependent on heparin size and sulfation pattern, where LMWH and N-desulfated heparin 
showed a reduced degree of bone resorption compared with the respective high-molecular 
weight and high-sulfate counterparts (Shaughnessy, Young et al. 1995). LMWH has been 
recommended for long-term use during pregnancy to decrease incidences of miscarriages 
(Greer and Hunt 2005). Although lactating women already have an increased calcium 
turnover from bone reserves, the heparin treatment is thought to have an additive impact 
on bone resorption, but the severity of the effect remains inconclusive (Lefkou, 
Khamashta et al. 2010). 
 
Heparin-induced thrombocytopenia (HIT) is a severe adverse effect from heparin therapy 
with an estimated incidence of 1-5 % in treated patients (Kelton 2002). The complication 
is initiated by the release of a small platelet factor, PF4, from activated platelets.  Some of 
the PF4 molecules remain associated with the platelet surface and facilitate charge-
dependent binding to heparin in the circulation. The complex acts as an epitope and is 
recognized by IgG antibodies. Receptors on the platelet surface consequently bind to the 
Fc region of the antibodies, leading to aggregation and further activation of the platelets, 
thus reinforcing the effect (Franchini 2005). These events extensively activate the 
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coagulation cascade, which can ultimately lead to thrombosis and cardiovascular 
complications in patients. Thrombocytopenia refers to a platelet decrease in the 
circulation, which in this case is caused by increased clearance of activated IgG-bound 
platelets (Chong 2003). Similarly to the effects of heparin on bone resorption described 
above, treatment with low-molecular weight fractions resulted in a lower incidence of 
HIT, likely due to reduced PF4 and platelet binding (Warkentin, Levine et al. 1995), 
(Hirsh and Raschke 2004).  
 
As commercial heparin is isolated from mammalian cells, contamination is possible and 
can cause additional adverse effects in the treated patients. The isolate can carry 
pathogens such as avian influenza virus or prions associated with bovine spongiform 
encephalopathy, depending on the source (Mendes, dos Santos et al. 2009). In 2008, 
several heparin batches as well as LMWH derivatives had to be withdrawn due to a 
contamination of chondroitin sulfate (CS), a glycosaminoglycan with a higher negative 
charge density than heparin. CS has relatively low anticoagulant activity, but can cause 
bradykinin production through the kinin-kallikrein pathway. Bradykinin causes 
vasodilation which can further lead to a severe drop in blood pressure (Li, Suwan et al. 
2009).  
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1.4 Structural Characterization 
 
1.4.1 SEC-MALLS 
 
Similarly with many other natural polysaccharides the synthesis of alginates is not 
template based, resulting in a range of different sized chains. When describing alginate 
chain size, commonly used characteristics are the molecular weight average (Mw) and the 
average number of monomers composing each chain, known as degree of polymerization 
(DP). 
  
Light scattering is an effective technique for determining the absolute mass of 
macromolecules, and can also give conformational data on polymers in solution. As the 
name implies, the principle of the technique is based on the fact that particles in a solution 
scatter light when irradiated. The incident light beam can be thought of as an oscillating 
electrical wave causing displacement of electrons, forming a dipole within the molecule. 
The dipole itself will in turn oscillate and emit new radiation in the form of scattered light. 
The amount of scattered light increases with the polarizability of the molecule, which is 
directly proportional to the refractive index (dn/dc) parameter characteristic for a polymer 
solution (Podzimek 2011). When studying small globular proteins with a narrow weight 
distribution, classical light scattering measured at a single angle is sufficient, as the 
intensity of the scattered light will be uniform in all directions. Size Exclusion 
Chromatography - Multi-Angle Laser Light Scattering (SEC-MALLS) is a technique 
more often employed when studying polysaccharides, which have a more extended 
conformation and can have a wide molecular weight distribution. Here, light scattering is 
measured at several angles, allowing mass determination of larger macromolecules as well 
as measurement of the geometric size of the individual molecules, expressed as the radius 
of gyration (RG or RZ). Injection of the sample through a size-exclusion column prior to 
detection results in a mass distribution curve where larger molecules are eluted out first, 
allowing analysis of the weight range of the individual samples and the relative disparity 
between samples. For the purpose of analyzing sulfated alginates, the SEC-MALLS data 
can additionally be used to assess degradation of the sulfated samples compared to an 
unmodified reference sample.   
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The molecular size averages measured in light scattering are the molecular number 
average (Mn) and molecular weight average (Mw) shown in equations 1.1 and 1.2, 
respectively. Mn is commonly expressed in terms of moles (n), where Mi is the polymer 
molecular weight. The more frequently used Mw emphasizes the impact of large chains, 
by incorporating the gathered mass of each polymer size in the sample, expressed as w. 
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       (1.2) 
  
The average number of monomers per alginate chain, or degree of polymerization (DP) is 
given by molecular number average divided by the monomer molecular weight (M0), 
shown in equation 1.3. The polydispersity of the samples expresses the width of the 
weight distribution and is calculated by dividing the molecular weight average by the 
number average (equation 1.4). A polydispersity value of one corresponds to uniform 
chain length in the solution, and the value increases with the width of the weight 
distribution.  
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1.4.2 NMR Spectroscopy 
 
Nuclear magnetic resonance (NMR) spectroscopy is the most widely used tool for 
structural characterization of organic molecules. The instruments and techniques have 
evolved profoundly over the last decades, allowing effective characterization of structure 
patterns, connectivity and dynamics in increasingly complex molecules. NMR 
spectroscopy is based on the presence of a nuclear spin momentum in certain atoms, 
therein most importantly 
1
H and 
13
C. When a static magnetic field is applied to a molecule 
in solution, a magnetic dipole arises and the nuclei orient themselves either parallel or 
antiparallel to the magnetic field (Lehninger, Nelson et al. 2008). During an NMR 
experiment the sample is irradiated with an electromagnetic pulse, causing the nuclei of 
the molecule to resonate at a frequency characteristic of the atom, its connectivity and 
molecular environment. Many of the atoms in a molecule are in a unique electromagnetic 
environment primarily due to associated electrons that create localized small magnetic 
fields when moving. Nearby electrons have a partially shielding effect on the nucleus, 
which counters the applied magnetic field and decreases the resulting resonance 
frequency. Conversely, less electrons around the nucleus means that the nucleus is 
exposed to a stronger magnetic field, causing it to resonate at a higher frequency 
(Doucleff, Hatcher-Skeers et al. 2011). Thus, one molecule can give rise to several 
resonating sine waves at a number of different frequencies increasing with the complexity 
of the molecule. This collection of wave signals is expressed as amplitude as a function of 
time, and is translated into an NMR spectrum through Fourier Transformation (FT). This 
operation organizes the individual signals in a plot with amplitude as a function of 
frequency, where a peak is assigned to each unique frequency (Figure 6).  The 
characteristic resonance patterns of atoms and knowledge of the electromagnetic 
influences within the molecule form the basis for obtaining structural data from an NMR 
experiment. 
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Figure 6: Fourier transformation of NMR signals in a (A) time-domain spectrum into a (B) 
frequency-domain spectrum. Adapted from (Doucleff, Hatcher-Skeers et al. 2011)). 
 
Interpretation of the NMR spectrum becomes more challenging when studying complex 
macromolecules such as proteins or polysaccharides. Structural data of such molecules 
can be achieved through the employment of various multidimensional NMR techniques. 
The nuclear spins of atoms are coupled to one another in the sense that magnetization can 
be transferred between them. This energy transfer can occur across a covalent bond, also 
known as J-coupling, or can be obtained with spatially close atoms through the 
phenomenon called the nuclear Overhauser effect (NOE). Multidimensional spectra 
provide information about the connectivity and spatial arrangement of the atoms through 
the correlation of frequency signals, allowing deciphering of otherwise complex one-
dimensional spectra.  
 
Proton and carbon NMR spectroscopy is commonly employed to determine the relative 
content of M and G units in alginates as well as the overall monomer sequence. To obtain 
an optimal NMR spectrum from an alginate sample it is beneficial to hydrolyze the 
alginate chains to reduce sample viscosity, while a calcium chelator such as 
triethylenetetraamine (TTHA) may be added to samples with high guluronic acid content 
to prevent aggregation and partial gelling. Additionally, alginate samples dissolved in 
deuterium oxide are commonly run at a high temperature (90 
o
C) to increase molecular 
motion and thus increase the resolution of the spectra (Grasdalen, Larsen et al. 1981). For 
the purpose of obtaining sequence data, it is convenient to divide the polymer sequence 
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into a collection of diads (MM, GG and MG) and triads (MMM, MMG, MGM, MGG, 
GMM, GMG and GGG). Electromagnetic coupling affects the resonance frequencies 
associated with an alginate monomer across the glycosidic bond, giving rise to 
distinguishable peaks depending on the identity of the adjacent monomers (Grasdalen, 
Larsen et al. 1981). Triad sequences can thus be assigned to these unique peaks, and the 
relative intensities can be used to calculate the triad fractions in the alginate sequence. The 
same principle can be applied when studying chemically modified alginates, as the 
addition of a new chemical group gives rise to novel chemical shifts in the spectrum. 
Interpretation of the spectrum becomes more challenging as the novel signals can be 
relatively weak and are also affected by neighboring monomers that can be either 
modified or unmodified. In the case of sulfation, each monomer can additionally have 
zero, one or two substitutions, further complicating the spectrum. Quantification of such 
chemical modifications to alginates thus requires high resolution spectra, sufficiently 
purified samples and unambiguous peak assignment.  
 
 
1.4.3 Infrared Spectroscopy 
 
Molecular covalent bonds are not static entities, and can undergo a number of vibrating 
motions. Analogous to a spring, a chemical bond can be stretched or bent in manners 
characteristic to the attached atoms and the electrostatic environment (Figure 7). 
Variations of these basic motions include symmetric and asymmetric stretching and in- 
and out-of-phase bending, also contributing to the IR spectrum (Stuart 2004).  
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Figure 7: Examples of basic motions of molecular bonds shown in a water molecule. Adapted from 
(Stuart 2004)). 
 
In normal modes of vibration all atoms in a molecule oscillate at the same frequency about 
their equilibrium position (Lambert 1998), but when a sample is irradiated with an 
electromagnetic beam, radiation in the infrared region is absorbed. Absorbed radiation is 
converted to molecular vibration, causing a transition between vibrational energy levels 
E1 and E2, where the energy difference between the two states is related to the frequency 
of the radiation (Lambert 1998). To obtain the IR spectrum, the recorded interference in 
transmission is transformed into either an absorption or a transmittance spectrum through 
Fourier transformation (FT) and plotted as a function of frequency, usually expressed in 
wavenumbers (cm
-1
) (Figure 8). Different motions of each bond (e.g. stretching or 
bending) absorb radiation at different frequencies giving rise to unique absorption bands 
in the IR spectrum. As some of these peaks are prominent and characteristic of a certain 
bond, an IR spectrum can be used to obtain structural information about the molecule. IR 
can also be used to assess the purity of a sample, or to identify new chemical bonds in a 
molecule through comparison with reference spectra which are widely available. 
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Figure 8: FTIR transmission spectrum of sodium alginate. Adapted from (Zhu, Yang et al. 2007) 
 
For alginates, FTIR can be used to estimate the proportion of M to G units by measuring 
the relative intensities of bands characteristic for each monomer (Sakugawa, Ikeda et al. 
2004). It is additionally a very useful technique to detect new chemical bonds from 
covalent modification reactions, as new peaks will appear when compared to an 
unmodified reference sample. It is, however, difficult to make precise quantitative 
assumptions from FTIR data as the absorption peak intensities are directly correlated to 
molecule concentration, necessitating meticulous sample preparation and instrument 
operation. 
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1.5 Aims of the Study 
 
The main objectives of the study were to create a heparin analog based on a chemically 
sulfated alginate, characterize it and assess protein binding and anticoagulating properties. 
Different concentrations (1-10 %) of the sulfating reagent were used to achieve different 
degrees of sulfation, while enzymatic epimerization was employed to increase the 
flexibility of the alginate. An important aim was to thoroughly characterize the structural 
properties of the sulfated alginates in terms of sequence, molecular weight, modification 
pattern and sulfation degrees in order to propose optimal properties for potential 
therapeutic use. To determine sulfation degrees, the modified alginates were studied using 
quantitative 
13
C-NMR techniques and through elemental analysis. NMR was also 
employed to study the modification pattern and assess selectivity of sulfation sites on the 
alginate when using the current modification techniques. Interaction between the sulfated 
alginate and known heparin-binding proteins was studied, and anticoagulating properties 
were investigated through a blood plasma clotting assay.   
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2 Materials and Methods 
 
2.1 Materials 
 
Epimerization and sulfation was performed on a purified polymannuronic acid ([η] = 940 
ml/g) produced from an AlgG negative strain of Pseudomonas fluorescens (Gimmestad, 
Sletta et al. 2003), by NOBIPOL, Trondheim, Norway. AlgE4 enzyme was isolated from 
Hansenula polymorpha, by SINTEF Trondheim, Norway. 99 % chlorosulfonic acid 
(ClSO3H) used for sulfation of alginates, as well as >= 99.5 % 4-
Morpholinepropanesulfonic acid (MOPS) used in epimerization, was purchased from 
Sigma-Aldrich Norway AS (Oslo, Norway). The sodium chloride and calcium chloride 
used was all of analytical grade and provided by Merck (Whitehouse Station, NJ, USA) 
and ethylenetriaminetetraacetic acid (EDTA) by BDH Prolabo®, VWR (Oslo, Norway). 
The deionized water used was Milli-Q ultra pure water, with a conductivity measured at 
0.7 µS.  
For the protein binding experiments, the human myeloma cell RPMI-8226 (American 
Type Culture Collection, Rockville, MD, USA) was used. The cells were grown in RPMI 
1640 (Gibco, Paisley, UK) supplemented with L-glutamine (100 µg/ml) and gentamicin 
(20 µg/ml), with 20 % Fetal Calf Serum (FCS). The medium was replenished twice 
weekly and the cells were cultured at 37 
o
C in a humidified atmosphere with 5 % CO2. 
The proteins used were Recombinant Human HGF by R&D Systems® (Minneapolis, MN, 
USA) and Fc
-
 hOPG from Amgen (Thousand Oaks, CA, USA). Heparin LEO®  (Mw 12-
15 kDa) provided by LEO Pharma (Ballerup, Denmark) was used for all protein-binding 
and anticoagulation experiments. The antibodies used were 10 µg/ml solutions of Primary 
HGF Antibody 2B5 IgG1 (Deparment of cancer research and molecular medicine, NTNU, 
Trondheim, Norway), Human Osteoprotegerin/TNFRSF11B MAb, Mouse IgG2A from 
R&D Systems®  and Mouse IgG1 pure for primary labeling. Goat-anti-mouse (GAM) 
FITC Antibody was used for all secondary labeling and was purchased from BD 
Biosciences (San Jose, CA, USA). The HEPTEST® kit was used in the anticoagulation 
assay, provided by American Diagnostica Inc. (Stamford, CT, USA). 
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2.2 C5 Epimerization 
 
Poly-M (4 g) was dissolved in deionized water. A buffer solution containing 50 mM 
MOPS at pH 6.9 with 2.5 mM CaCl2 and 10 mM NaCl was added to the poly-M solution 
and preheated for one hour at 37 
o
C before adding 30 mg AlgE4 enzyme dissolved in 
deionized water. The epimerization proceeded at 37 
o
C for 48 hours under stirring before 
the reaction was terminated by adding a 50 mM EDTA solution. The alginate was 
dialyzed and freeze dried. 
 
End-point analysis of the poly-M reference and the epimerized sample were recorded at 
90 
o
C on a Bruker Avance DPX 300 MHz spectrometer equipped with 5 mm QNP  probe. 
The spectra were recorded, processed and analyzed using the software TopSpin versions 
2.1 and 3.0. The alginate samples were dissolved in D2O with 5 µl 1 % trimethylsilyl 
propionate (TSP) as reference. 
 
 
2.3 Acid Hydrolysis 
  
Poly-M and poly-MG alginates were dissolved in deionized water and the pH was lowered 
to 5.6 using 0.1 M HCl. The alginate was then heated to 95 
o
C for one hour, followed by 
immediate cooling and further lowering of the pH to 3.8. The solution was reheated to 95 
o
C for 50 minutes before cooling and the pH was adjusted to 6.8. The alginate was 
dialyzed and finally freeze dried. 
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2.4 Sulfation of Alginates 
 
Three poly-M samples were sulfated using chlorosulfonic acid concentrations of 2 %, 5 % 
and 10 %. For the three poly-MG samples, ClSO3H concentrations of 1 %, 2 % and 5 % 
were used due to the higher solubility associated with the alternating sequence. ClSO3H 
was added to formamide, giving a total reaction volume of 40 ml. Hydrolyzed dry alginate 
(1 g) was then added to each sample, and the reaction proceeded at 60 
o
C for 4 hours. The 
alginate was precipitated from the mixture by adding 180 ml acetone and was centrifuged 
for 6 minutes at 5000 rpm (5810 g) on a Beckman Coulter Allegra® X-15R centrifuge. 
Water was added to the suspension and the pH was adjusted to 7.0 to dissolve the alginate. 
The pH of the solution was then lowered to 3.0 to de-ionize the alginate, followed by 
dialysis to remove excess ions and formamide. The pH was finally raised back to 7.0 and 
the alginate was freeze dried. 
 
 
2.5 Purification of Sulfated Alginates 
 
In order to remove traces of lipopolysaccharides (LPS) from the alginate, all samples were 
purified using Millistak+® Depth Filters in µPod™ format CR40 with cellulose fiber 
media combined with activated carbon, provided by Millipore (Billerica, MA, USA). The 
tubing was sterilized by rinsing with 0.1 NaOH and water, and the filters were rinsed 
extensively with water and 0.1 M HCl to remove carbon residues and excess ions. 
Alginate solutions of 500 mg dissolved in 100 ml deionized water were pumped through 
the filter at a rate of 15 ml/min, in recirculation over night. The final filtrate was collected 
in a sterile container, dialyzed and freeze dried.  
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2.6 FTIR Spectroscopy 
 
FTIR samples were prepared by mixing 15 mg ground alginate with 600 mg analytical 
grade KBr powder. For each sample, 100 mg of the mixture was compressed into a 
transparent wafer using an applied load of 10 tons. The spectra were obtained at room 
temperature using a Bruker Vertex 80 system, in the range 400 cm
-1
 to 4000 cm
-1
.  
 
 
2.7 SEC-MALLS 
 
Sulfated and unmodified poly-M and poly-MG samples (10 mg) were dissolved in 1 ml 
deionized water and sterile filtrated through a 0.22 µm Millipore filter unit prior to SEC-
MALLS. Measurements were carried out on a HPLC system consisting of a Degasys DG-
1210 degasser by Dionex, together with an LC-10AD pump and an SCL-10A VP auto-
injector by Shimadzu. The column used was connected to a Dawn Heleos II light 
scattering detector and an Optilab T-rEx RI detector, both by Wyatt Technology 
Corporation (Santa Barbara, CA, USA). 
A refractive index (dn/dc) of 0.15 ml/g was employed for all analyzed samples, and the 
data were recorded and processed using the software Astra (version 4.90.07), by Wyatt 
Technology Corporation. 
 
2.8 Elemental Analysis 
 
The sulfur contents of the sulfated alginate samples were analyzed through high-resolution 
inductively coupled plasma mass spectrometry (HR-ICP-MS) at the Institute of chemistry, 
NTNU, by Syverin Lierhagen. Samples were prepared by dissolving 5 mg of dried 
alginate in 0.1 M HNO3 (45 ml). The measured sulfur content was used to estimate the 
degree of sulfation (DS), defined as the average number of sulfate groups per alginate 
monomer, through the following mass-balance equation where x represents the DS: 
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C6O6H5 + (x+1)Na
+
 + xSO3
-
 + H2O = Total monomer mass      (2.1) 
 
It was assumed in equation 2.1 that approximately 10 % water was associated with the 
alginate and one sodium counter-ion with each negative charge. DS values were plotted 
against the corresponding theoretical sulfur content, creating the standard curve shown in 
Appendix B. A second degree function was fitted to the curve, and the DS values 
corresponding to the measured sulfur content of the sulfated alginate samples were 
calculated. 
 
 
2.9 13C NMR Analysis 
 
All 
13
C NMR spectra were recorded at 40 
o
C on a NMR Bruker Avance 600 MHz 
spectrometer equipped with a z-gradient CP-TCI probe. The spectra were recorded, 
processed and analyzed using the software TopSpin versions 2.1 and 3.0. The alginate 
samples were dissolved in D2O with 5 µl 1 % trimethylsilyl propionate (TSP) as 
reference. The
13
C NMR spectra were recorded using an inverse gated decoupling pulse 
scheme with a 30° flip angle and 5 seconds intrascan delay. Signal assignations were 
made through the employment of multi-dimensional NMR techniques, by Finn L. 
Aachmann at the Department of biotechnology, NTNU. Estimations of the sulfation 
degrees (DS) for the sulfated poly-M samples were made by integrating the signals and 
calculating the area fraction of peaks raised from sulfated carbons C2 and C3 through, as 
shown in equation 2.2. 
 
                                       (2.2) 
 
The DS was also estimated with respect to C1, by calculating the fraction of signals 
associated with monosubstituted (S) and disubstituted monomers (SS) relative to the total 
integrated C1 signals, as shown in equation 2.3. 
 
                               (2.3) 
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2.10 Inhibition of Cell Surface Protein Binding 
 
2.10.1 Hepatocyte Growth Factor (HGF) 
  
Stock solutions of sulfated alginates were prepared by dissolving 10 mg alginate in 0.5 ml 
deionized water and sterile filtration of the solutions using a 0.22 µm Millipore filter unit. 
Myeloma RPMI cells were incubated in a 1 µg/ml solution of HGF in sterile phosphate 
buffered saline (PBS) with 0.1 % bovine serum albumin (BSA), for 15 minutes. The cells 
were stimulated for 10 minutes using increasing concentrations of heparin or sulfated 
alginates (0.001-10 µg/ml), as well as high-concentration samples of the non-sulfated 
poly-M and poly-MG alginates (3 and 10 µg/ml), diluted in 100 µl PBS/0.1 % BSA. HGF 
antibody (Ab) 2B5 was added to samples stimulated with HGF, while an isotype control 
sample was labeled with Mouse IgG1 pure Ab for 25 minutes. Secondary labeling was 
performed by adding GAM FITC Ab to all samples, followed by incubation for another 25 
minutes. The cells were finally re-suspended in PBS. All samples were washed with 2 ml 
of a PBS/0.1 % BSA solution and centrifuged between each incubation step.  
 
  
2.10.2 Osteoprotegerin (OPG) 
 
Myeloma RPMI cells were incubated with 5 µg/ml OPG in sterile PBS/0.1 % BSA for 15 
minutes and stimulated with a single concentration (3 µg/ml) of heparin, sulfated alginates 
and unmodified poly-M and poly-MG alginates. The cells were labeled using Human 
OPG MAb followed by GAM FITC Ab following the same protocol as described above 
for HGF. 
 
Fluorescing antibody-labeled cells were detected by flow cytometry using a FACS-LSRII 
instrument, by BD, and the data were recorded and subsequently analyzed using the flow 
cytometry analysis software FlowJo (Tree Star, Ashland, OR).  
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2.11 In vitro Measurement of Plasma Coagulation Time  
  
Anticoagulant properties of the sulfated alginates were studied using the HEPTEST® 
assay, measuring the increase in normal human plasma (NHP) coagulation time as a 
function of factor Xa inactivation. The selected dose range of heparin was 1.7-13.9 µg/ml 
while a range of 7.0-222.4 µg/ml was chosen for the sulfated alginates based on initial 
experiments. Heparin or sulfated alginate samples diluted in NHP (100 µl) were heated to 
37 
o
C in plastic flow tubes. Factor Xa reconstituted in distilled water (100 µl) at 25 
o
C was 
added to the samples, followed by 100 µl RECALMIX, in accordance with the HEPTEST 
- HI ASSAY protocol. The time from added RECALMIX to observed solidification of the 
plasma was recorded.  
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3 Results 
 
3.1 C5 Epimerization of Polymannuronic Acid 
 
Polymannuronic acid (poly-M) was epimerized using the C5 epimerase AlgE4. The 
1
H 
spectra of the poly-M template and the resulting epimerization product are shown in 
Figure 9.  
 
Figure 9: 
1
H NMR spectra of the anomeric regions of the (A) epimerization product after 
epimerization of (B) polymannuronic acid, with AlgE4. The assignation marks protons associated 
with carbon 1 of mannuronic acid or guluronic acid, along with the identity of the adjacent monomer. 
Samples were dissolved in D2O and recorded on a 300 MHz spectrometer at 90 
o
C. 
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Spectrum B showed a novel peak at approximately 5.1 ppm, which was assigned to the 
anomeric proton of C1 on α-L-guluronic acid. The anomeric M-M1 signal in the 
polymannuronic acid, at approximately 4.65 ppm, had diminished noticeably, appearing 
as a shoulder on the adjacent G-M1 peak risen in spectrum A of Figure 9. Integration of 
the anomeric proton signals observed at ~4.7 ppm for β-D-mannuronic acid and ~5.1 ppm 
for α-L-guluronic acid showed a guluronic acid fraction (FG) of 0.46 in spectrum B. From 
the epimerization pattern of AlgE4 previously described and the resulting FG, the 
epimerization product was designated as an alginate containing almost exclusively MG-
blocks (poly-MG). 
 
 
3.2 FTIR Spectroscopy 
 
FTIR spectral data for sulfated poly-M and poly-MG samples are presented in Figure 10 
and Figure 11. Compared with the unmodified M and MG samples, new peaks were 
observed respectively at 1260 cm
-1
 and 1250 cm
-1
 for the sulfated derivatives, attributed to 
asymmetrical S=O stretching (Fan, Jiang et al. 2011). The transmittance values of this 
peak were approximately equal for the 10 % S-M and 5 % S-M samples shown in Figure 
10, while a lower intensity was observed in the same peak for the 2 % S-M sample.  
 
A similar pattern was observed in the MG spectra shown in Figure 11, where the most 
prominent S=O peak was observed in the 5 % S-MG sample. The same peak of the 2 % S-
MG curve showed a weaker intensity compared to the 1 % S-MG sample. The former 
sample did, however, exhibit a weaker signal along the whole spectrum with lower 
recorded transmittance values at the referential alginate peaks as well. As the 
transmittance is correlated to molecular concentration in the sample, the result indicated a 
lower alginate concentration in the prepared wafer relative to the other samples. 
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Figure 10: FTIR transmission spectra of solid KBr pellet samples of poly-M alginates; unmodified 
(M) and sulfated (S-M) using chlorosulfonic acid concentrations of 2 %, 5 % and 10 %. The spectra 
were recorded at room temperature. 
 
 
 
Figure 11: FTIR transmission spectra of solid KBr pellet samples of poly-MG alginates; unmodified 
(MG) and sulfated (S-MG) using chlorosulfonic concentrations of 1 %, 2 % and 5 %. The spectra 
were recorded at room temperature. 
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An additional novel peak was observed at approximately 600 cm
-1
 in all the sulfated 
alginates, most prominently shown in Figure 10. The peak could not be assigned with 
confidence due to the low resolution in the frequency region, but was presumed to have 
risen from the attached sulfate group rather than sample impurities, due to a transmittance 
shift pattern similar to that of the S=O peaks observed at 1250 and 1260 cm
-1
 in the 
figures above.  
 
 
3.3 SEC-MALLS 
 
The molecular weight averages and distributions of the sulfated alginate samples as well 
as the unmodified poly-M and poly-MG alginates were studied using SEC-MALLS. The 
measured weight and number averages, corresponding DP estimations and polydispersity 
values are shown below in Table 1, and the mass distributions are shown Figure A 1 and 
Figure A 2 in Appendix A. 
 
Table 1: SEC-MALLS data for poly-M and poly-MG alginates sulfated using chlorosulfonic acid 
concentrations of 1 %, 2 %, 5 % and 10 % compared with unmodified (M and MG) alginates. Mn = 
Molecular number average, Mw = Molecular weight average, DP = Degree of polymerization. 
Sample Mn (kDa) Mw (kDa) Polydispersity DP 
Poly-M 23.8 32.1 1.35 120 
2 % S-M 23.0 30.6 1.33 116 
5 % S-M 22.1 31.4 1.43 112 
10 % S-M 24.2 32.6 1.35 122 
Poly-MG 11.8 14.3 1.21 60 
1 % S-MG 12.1 17.0 1.41 61 
2 % S-MG 12.8 18.4 1.43 65 
5 % S-MG 15.8 22.9 1.45 80 
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The calculated weight averages of all the poly-M samples were found to be approximately 
twice that of the poly-MG samples, while a relatively small difference in molecular 
weight was observed within the samples of each alginate type. For poly-MG, higher Mw 
and Mn values were associated with increasing concentration of the sulfating reagent used. 
A similar tendency was observed in the molecular weight average of the sulfated poly-M 
samples, but the unmodified alginate showed a higher value than two of the sulfated 
samples, and no direct relationship was observed between the sulfating conditions and the 
molecular number average of the poly-M samples. 
 
The chromatography curves depicted in Appendix A showed no apparent change in the 
mass distribution of the poly-MG samples as a result of the sulfation reaction. A small 
shift was observed in the sulfated poly-M samples compared to the unmodified reference 
sample, where the 5 % S-M and 10 % S-M samples exhibited slightly longer elution time, 
suggesting a minor degree of degradation. The low amplitude of the S-MG curves was 
assumed to be caused by a lower alginate concentration in the prepared samples.  
 
 
3.4 Elemental Analysis 
 
The sulfur contents of the sulfated alginate samples were measured through elemental 
analysis using HR-ICP-MS and are shown below in Table 2 along with the corresponding 
estimations of the degrees of sulfation (DS). The calculation of DS is elaborated in 
Appendix B. For the sulfated poly-MG samples, the DS values increased with the 
concentration of the sulfating reagent used, where the 5 % S-MG sample showed the 
highest sulfate content with an average of 1.08 sulfate groups per monomer. The highest 
estimated DS in the poly-M samples was attained when using a concentration of 5 % 
chlorosulfonic acid, with 0.87 sulfate groups per monomer. When doubling the 
concentration of the sulfating reagent in the 10 % S-M sample, a decrease of the DS was 
observed.  
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Table 2: Measured sulfur contents and estimated degrees of sulfation (DS) of poly-M and poly-MG 
alginates, sulfated using chlorosulfonic acid concentrations of 1 %, 2 %, 5 % and 10 %, from 
elemental analysis using high resolution ICP-MS. 
Sample Sulfur content (µg/g) Sulfur content (%) DS 
2 % S-M 16 124 1.61 0.12 
5 % S-M 91 359 9.14 0.87 
10 % S-M 82 222 8.22 0.76 
1 % S-MG 10 774 1.08 0.08 
2 % S-MG 60 921 6.09 0.53 
5 % S-MG 106 993 10.70 1.08 
 
Only a small amount of sulfur was detected in the 2 % S-M and the 1 % S-MG samples, 
resulting in the lowest calculated DS values. It was observed that the 2 % S-M sample 
failed to dissolve completely in the HNO3 prior to analysis.  
 
 
3.5 13C NMR Analysis 
 
The sulfation degrees and substitution patterns of the sulfated alginate samples were 
studied using 
13
C NMR with unmodified poly-M and poly-MG alginates as reference 
spectra. The spectra of the sulfated alginates revealed new peaks originating from carbon 
atoms directly attached to sulfate group and indirectly from adjacent carbons through 
coupling mechanisms. The recorded spectra of poly-M and its sulfated derivatives are 
shown in Figure 12 with proposed peak assignation. 
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Figure 12: 
13
C NMR spectra of unmodified poly-M and sulfated poly-M (S-M) alginates using 
chlorosulfonic acid concentrations of 2 %, 5 % and 10 %. S = monosulfated monomer, SS = disulfated 
monomer, * = unmodified monomer adjacent to sulfated monomer. Samples were dissolved in D2O 
and the spectra were recorded at 40 
o
C on a 600 MHz spectrometer with an inverse gated decoupling 
scheme, 30
o
 pulse angle and 5 seconds intrascan delay. 
 
 
A diverging of the anomeric carbon signal (M1) at approximately 103 ppm was observed 
as a result of the sulfation. The 5 % S-M spectrum in particular showed two prominent 
peaks at a lower resonance frequency than the unmodified C1 signal, where the least 
intense peak was proposed to arise from C1 on a mannuronic acid monomer where only 
C2 was sulfated, while the adjacent peak at the lower resonance frequency was assigned to 
C1 of an M unit where both C2 and C3 were sulfated.  
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Novel peaks in the 78-82 ppm region of the sulfated alginates were not readily 
distinguishable, and as they were not directly relevant for the DS estimations, the signals 
were collectively assigned as derivative signals of C4 and C5. A distinct shift to a higher 
resonance frequency was observed in the sulfated C3 peak of mannuronic acid (M3S), 
which appeared at approximately 77 ppm, with the adjacent C3 signal representing a 
disulfated monomer. The most distinguished newly formed peak was that proposed as the 
sulfated C2 carbon found at 72 ppm, at a lower resonance frequency than the unmodified 
C2. In the 5 % S-M and 10 % S-M spectra, an adjacent peak of lower intensity was 
observed at a lower frequency than the M2S signal, assigned to C2 on a disulfated M unit.   
 
Estimations of the degrees of sulfation for the samples were made through integration of 
the signals with respect to C1 or C2 and C3, and are shown below in Table 3.The signals 
assigned to monosulfated and disulfated monomers were included in the same integral 
when calculating the DS. Integration of the C1 signals resulted in DS estimations 18 %, 27 
% and 35 % higher than the estimations based on C2/C3 integration for the 2 % S-M, 5 % 
S-M and 10 % S-M samples, respectively. The integration values used for the calculations 
are listed in Appendix C. 
 
Table 3: Estimated degrees of sulfation of poly-M alginates sulfated using chlorosulfonic acid 
concentrations of 2 %, 5 % or 10 %, based on integration of 
13
C NMR signals of either C1 or C2 and 
C3. Integration values are listed in Appendix C. 
Sample DS (C1) DS (C2/C3) 
2 % S-M 0.38 0.21 
5 % S-M 0.89 0.70 
10 % S-M 0.69 0.51 
 
 
The 
13
C spectra of poly-MG and its sulfated derivatives are shown in Figure 13 with 
assignation for the unmodified alginate sample. 
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Figure 13: 
13
C NMR spectra of unmodified poly-MG and sulfated poly-MG (S-MG) alginates using 
chlorosulfonic acid concentrations of 1 %, 2 % and 5 %. Samples were dissolved in D2O and the 
spectra were recorded at 40 
o
C on a 600 MHz spectrometer with an inverse gated decoupling scheme, 
30
o
 pulse angle and 5 seconds intrascan delay. 
 
Sulfation of the poly-MG samples resulted in more complex NMR spectra compared with 
poly-M. The relatively low sulfation degree of the 1 % S-MG sample estimated from 
elemental analysis was reflected in a spectrum similar to that of the unmodified poly-MG. 
For the 2 % S-MG and 5 % S-MG samples, a large diverging of the signals particularly 
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associated with C4 of the M and G monomers and C5 of M was observed. The intensity of 
the G2 signal was visibly reduced in the 2 % S-MG, while two new peaks appeared at a 
lower resonance frequency. The G2 peak was not observed at all in the 5 % S-MG 
spectrum, and only one peak at approximately 66 ppm was observed at a lower resonance 
frequency relative to G2. The G3 signal at 72 ppm did not decrease noticeably as a result 
of sulfation, while a split signal was observed in the 5 % S-MG sample at the same 
resonance frequency. In the C1 region an amplification of the signals in the 98-101 ppm 
region was observed, while the G1 signal was greatly reduced in the 5 % S-MG sample, as 
seen with the G2 peak. The M2 and M3 signals were relatively unchanged from the poly-
MG reference in the 1 % S-MG and 2 % S-MG, although some apparent splitting of the 
signals had occurred in the latter sample. Both signals diminished notably in the 5 % S-
MG sample, and shifts of the M2 and M3 peaks to different resonance frequencies were 
observed. 
 
 
3.6 Inhibition of Cell Surface Protein Binding 
 
Hepatocyte growth factor (HGF) and osteoprotegerin (OPG) have previously been shown 
to bind heparin, and were in the present study evaluated for their ability to bind sulfated 
alginates. Human myeloma RPMI cells were incubated with HGF or OPG and treated 
with heparin or sulfated alginates to release the proteins from the cell surface. Following 
treatment, the proteins were labeled with fluorescent antibodies and flow cytometry was 
employed to measure the mean fluorescence (MFI) of the cell samples, corresponding to 
the amount of remaining cell-bound proteins. A protein-stimulated, untreated cell sample 
was used as negative control, while the isotype control sample was treated with a primary 
antibody unable to bind HGF or OPG, thus serving as a positive control. The sulfated 
alginates 2 % S-MG, 5 % S-MG, 5 % S-M and 10 % S-M were shown to be the most 
potent samples in initial experiments (Figure D 2, Appendix D), and were selected for all 
proceeding protein binding experiments as well as the anticoagulation assay later 
described. 
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3.6.1 Hepatocyte Growth Factor (HGF) 
 
The HGF-stimulated untreated sample was used as negative control equivalent to 100 % 
cell-bound HGF at zero treatment concentration set to 0.0001 µg/ml. The measured mean 
MFI values (Table D 1, Appendix D) for all samples were related to the negative control 
and graphed as percent cell-bound HGF as a function of treatment concentration, as 
shown in Figure 14, with guidance lines showing the proposed dose-response curve. 
 
 
 
Figure 14: Release of HGF from myeloma RPMI cell surface by treatment with heparin or poly-M 
and poly-MG alginates either unmodified or sulfated using chlorosulfonic acid concentrations of 2 %, 
5 % and 10 %, as a function of treatment concentration. Mean fluorescence intensities were recorded 
by flow cytometry and converted to percent cell-bound HGF in reference to the untreated control 
sample. The S-M and S-MG samples were tested in separate experiments. 
 
A dose dependency was observed for the effect of heparin and sulfated alginate species 
used, where maximal HGF releasing occurred around 3 µg/ml treatment concentration for 
all samples as the MFI values approached that of the positive control sample. When using 
a dose of 0.01 µg/ml, neither of the samples showed any appreciable reduction in cell-
bound HGF, indicating a thinning out of the measured effect. The apparent decrease in 
cell-bound HGF at a treatment concentration of 0.001 µg/ml for 5 % S-MG and 10 % S-M 
was assumed to be caused by inadequate sample preparation as the aberration was not 
observed in repeated experiments.  
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To evaluate the relative efficacy of the samples within the response window, the 
inhibitory concentration at 50 % cell-bound HGF (IC50) was studied. At this value heparin 
showed to be the most efficacious and retained high protein binding activity at 0.1 µg/ml 
treatment concentration, while 5 % S-M, 10 % S-M and 5 % S-MG showed a relatively 
similar impact where the effect was nearly thinned out at the same concentration. Of all 
the tested samples in the current experiment, 2 % S-MG was the least effective in 
displacing HGF from the cell surface, as the amount of cell-bound protein diminished 
noticeably when lowering the treatment concentration from 1 µg/ml to 0.3 µg/ml. As an 
additional control, treatments of non-sulfated poly-M and poly-MG alginates were tested 
at concentrations of  3 µg/ml and 10 µg/ml. All four of the unmodified samples showed 
MFI values similar to that of the negative control, indicating that no measureable HGF 
binding and release from the cells had occurred as a result of the treatments, despite the 
high doses. 
   
 
3.6.2 Osteoprotegerin (OPG) 
 
An OPG-stimulated untreated sample was used as a negative control, while the isotype 
control labeled with a non-binding primary antibody was set as a positive control in the 
experiment. Measured MFI values from flow cytrometry were converted to percent cell-
bound OPG in relation to the negative control (Table D 3, Appendix D), and the results of 
the experiment are shown in Figure 15. A concentration of 3 µg/ml was used for all 
treatments. 
 
Using non-sulfated poly-M and poly-MG alginates resulted in no appreciable release of 
OPG from the cell surface, with recorded MFI values equivalent to that of the untreated 
sample. Heparin and the four sulfated alginate samples used showed an almost equal 
effect at the given treatment concentration, although none reached the limit value of the 
positive control, as was observed in the HGF-binding experiment. 
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Figure 15.: Release of OPG bound to myeloma RPMI cell surfaces through treatment with 3 µg/ml 
solutions of heparin and poly-M and poly-MG alginates either unmodified or sulfated using 
chlorosulfonic acid concentrations of 2 %, 5 % or 10 %. Mean fluorescence intensities were recorded 
by flow cytometry and converted to percent cell-bound OPG in reference to the untreated control 
sample. 
 
 
3.7 In vitro Measurement of Coagulation Time 
 
Increasing doses of heparin (1.7-13.9 µg/ml) and sulfated alginates (7.0-222.4 µg/ml) 
were added to normal human plasma followed by supplementation of factor Xa, and the 
time required for visible coagulation was recorded. A pure plasma sample with factor Xa 
was set as a zero concentration negative control. The resulting plasma coagulation times 
from sulfated alginate and heparin treatments are graphed below in Figure 16 and Figure 
17, respectively, with guidance lines representing the proposed dose-response curves. 
Concentrations used and the corresponding coagulation times in seconds are listed in 
Appendix E. 
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Figure 16: Recorded coagulation times (s) of normal human plasma supplemented with factor Xa and 
treated with poly-M and poly-MG alginates either unmodified or sulfated using chlorosulfonic acid 
concentrations of 2 %, 5 % or 10 %, as a function of treatment concentration. 
 
 
 
Figure 17: Coagulatime time (s) of normal human plasma supplemented with factor Xa and treated 
with heparin as a function of heparin concentration. 
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A higher concentration of the sulfated alginate samples was required to appreciably 
increase the coagulation time of the plasma in comparison with heparin. For the 2 % S-
MG and both S-M samples, a steady non-proportional rise in the coagulation time was 
observed with increasing sample concentrations, while the plasma samples treated with 5 
% S-MG showed a steeper exponential-like increase in coagulation time within the dose 
range, similar to that of heparin shown in Figure 17. When the concentration was 
increased to 222 µg/ml (not shown), coagulation was achieved only in the 2 % S-MG (41 
seconds), while the remaining samples failed to coagulate after 10 minutes had passed. To 
evaluate the effect of sulfation, unmodified poly-M and poly-MG alginates were studied 
in parallel at concentrations of 56 µg/ml and 111 µg/ml. Treatment with non-sulfated 
poly-M and poly-MG alginates showed no measurable effect on the plasma coagulation, 
with recorded times equivalent to that of the negative control sample (21 s).  
 
An earlier coagulation experiment performed under the same conditions, but using plasma 
from a different donor, showed the same relative efficacy between the sulfated alginate 
samples. However, a steep increase in coagulation time was seen at 56 µg/ml for the 5 % 
and 10 % S-M samples, similar to that of 5 % S-MG at 111 µg/ml shown in the results 
above. Treatment with the 2 % S-MG sample showed the same result in both experiments, 
exhibiting a slow, linear increase in coagulation time as a function of treatment 
concentration. 
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4 Discussion 
 
Chemical sulfation of poly-M and poly-MG alginates was successfully achieved, evident 
in the elevated sulfur content measured through elemental analysis and the appearance of 
a novel FTIR peak corresponding to the S=O double bond of a sulfate group. While not 
quantifiable due to some sample concentration differences, the FTIR spectra showed the 
bond present in all sulfated alginate samples and absent in the poly-M and poly-MG 
reference curves. The carbon NMR spectra revealed several new peaks with signal 
intensities strongly affected by the chlorosulfonic acid concentration used for sulfation. 
The most prominent changes in the NMR spectra were associated with C2 and C3, 
indicating a modification occurrence at these carbons. Furthermore, no significant 
amounts of reaction by-products or other impurities were observed when interpreting the 
NMR spectra, indicating that the samples were sufficiently purified following sulfation. 
 
Although a clear effect was seen of increasing the chlorosulfonic acid concentration on the 
resulting degrees of sulfation estimated by elemental analysis, no direct relationship was 
shown. One of the reasons for the unpredictable response observed may have been partial 
precipitation of the alginate due to the acidic conditions of the sulfation reaction. The 
solubility of the alginate is dependent on the acid strength as well as alginate sequence and 
molecular weight, which resulted in varying degrees of precipitation between the samples 
used, particularly for the poly-M samples. There was no visible precipitation of the poly-
MG during the reaction, resulting in a somewhat more predicted response with regard to 
the estimated sulfation degrees, where the DS value increased with the concentration of 
the chlorosulfonic acid used. Precipitation may shield parts of the polymer towards the 
surrounding acid and decrease degradation, but it also lowers the exposure to the sulfating 
reagent and may thus limit the maximal sulfation degree. Partial precipitation of the 
alginates would also be expected to result in heterogeneous sulfation patterns, as parts of 
the alginate would be unexposed to the sulfating reagent. Conversely, homogenous 
sulfation, with random sulfate distribution along the whole length of the polysaccharide 
chain, would have been expected with a fully dissolved and exposed alginate. Although 
not apparent due the complexity of the sulfated poly-MG 
13
C NMR spectra, it is 
reasonable to expect that a more homogenous sulfation of the poly-MG alginates occurred 
as a result of the higher solubility observed during the sulfation reaction, compared to 
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poly-M. The cause of the higher solubility was assumed to be the higher flexibility of the 
polyalternating alginate. As the poly-MG alginate is also more prone to acidic 
degradation, the lower chlorosulfonic acid concentrations used (1 %, 2 %, 5 %) were 
favorable considering that no apparent degradation was observed from the SEC-MALLS 
data. The poly-M alginates were sulfated using higher chlorosulfonic acid concentrations 
at 2 %, 5 % and 10 %, and there were indications of some degradation in the two latter 
samples from the mass distribution curves shown in Appendix A. The relatively higher 
degradation rate of poly-MG alginates did, however, result in a lower weight average 
compared to the poly-M samples due to identical acid hydrolysis protocols prior to 
sulfation, which was evident when comparing Mw values non-sulfated poly-M and poly-
MG samples, shown in Table 1. 
 
Considering the light scattering data for the sulfated poly-MG samples, the observed 
increase in Mw was reasonable as an attached sulfate group adds nearly 50 % to the 
molecular weight of each monomer, and more if counting an additional sodium counter-
ion associated with each sulfate group. On the other hand, degradation of the samples 
would have resulted in a decrease in Mw, which was neither apparent from the 
chromatography curves nor the measured polydispersity. It was, however, not feasible to 
make precise estimations of the molecular weights and DS values for the sulfated 
alginates based on these data, as the sulfation alters the structural characteristics of the 
alginate in a manner that would have required a different refractive index (dn/dc) input 
value. The dn/dc value would in principle also differ between varying degrees of sulfation, 
requiring quantification prior to SEC-MALLS and experimental determination of dn/dc. 
The refractive index affects the calculation of the molecular weight averages, which may 
have contributed to the aberrations observed in the sulfated poly-M samples. The obtained 
SEC-MALLS data were still valid for comparing the weight average of the unmodified 
poly-M and poly-MG samples as well as the polydispersity of all samples, which is 
independent of dn/dc. 
     
The NMR spectra of all the sulfated poly-M samples showed a greater intensity of the 
signals assigned to C2 of the single-sulfated monomer (M2S) compared to the equivalent 
peak of C3 (M3S) (Figure 12). This observation indicated a substitution preference most 
likely to be caused by steric hindrance from the alginate's conformation towards the 
relatively bulky sulfate group. There were, however, distinguished signals showing 
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substitution of both C2 and C3 on a single mannuronic acid monomer, enabling utilization 
of both sulfation sites simultaneously despite the apparent C2 preference. Considering that 
some precipitation of the alginate was observed during sulfation of the poly-M samples, 
partial shielding from the surrounding chlorosulfonic acid may have affected the resulting 
sulfation pattern. 
 
The complexity of the sulfated poly-MG carbon spectra (Figure 13) prevented peak 
assignation with certainty. That would have required a sulfated poly-G reference as well 
as in-depth study using multidimensional NMR techniques. In addition to introducing 
several more peaks than in the poly-M alginates, sulfation of the poly-MG alginates also 
showed dissimilar shifting patterns in the resonance frequencies due to the different 
conformation of the alternating sequence. The disappearance of the G2 peak in the highly 
sulfated 5 % S-MG sample indicated a high degree of substitution at C2 of the G 
monomer. Considering the C1 region, a greater decrease in intensity was observed for the 
G1 signal compared with the adjacent M1 peak. Due to the intricate signal diverging it 
was not possible to identify the corresponding signals on the sulfated monomers with 
sufficient confidence, but the greater impact of sulfation on the G1 signal suggested a 
preference for substitution on the guluronic acid monomer in the current study. The 
diminished M2 and M3 signals in the 5 % S-MG sample did, however, indicate sulfation 
at these carbons as well. As the G3 signal intensity was not appreciably reduced from 
sulfation, the apparent signal splitting at 72 ppm was presumed to be the result of a newly 
formed peak corresponding to a sulfated C2 or C3 of the M monomer. The relatively low 
effect of the sulfation reaction on the G3 signal also indicated that C3 on the G monomer 
was not the primary substitution target, as was observed with M3 in the sulfated poly-M 
spectra. 
 
Attempted quantification of the DS in sulfated poly-M samples through 
13
C NMR resulted 
in non-matching DS values when integrating with respect to C1 as opposed to C2 and C3 
(Table 3). Although the DS roughly corresponded to the elemental analysis data shown in 
Table 2, the estimations were not feasible due to the disparity of the values for each 
sample. Precise quantification of natural substances using carbon NMR can be 
challenging due to a low abundance of the 
13
C isotope and because of the spin-lattice 
relaxation time (T1) of 
13
C, which is typically very long compared to 
1
H. The long T1 
necessitates a long recycle delay between scans, making the whole experiments 
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exceedingly time-consuming. In the present study, a 5 second intrascan delay to a 30
o
 
pulse was applied, corresponding to a pulse sequence recycle delay of approximately 15 
seconds. It has been indicated that a longer recycle delay, of at least 20 seconds, is 
required to achieve full relaxation, and thus precise quantification from carbohydrate 
13
C 
NMR spectra (Bubb 2003). The DS values obtained from elemental analysis were 
therefore considered more accurate estimates in the present study. Nonetheless, elemental 
analysis is, similar to quantitative FTIR analysis, highly dependent on the alginate 
concentration in the sample. A weaker signal was observed in the FTIR spectrum of the 2 
% S-MG sample (Figure 11), indicating a lower alginate concentration despite meticulous 
weighing of the dried alginate samples. The aberration is likely due to the anionic 
character of the alginates, which can cause inclusion of salts, water and possibly other 
impurities in the samples, thus adding to the total dry weight. It was also observed that the 
2 % S-M alginate failed to dissolve completely in HNO3 during sample preparation for the 
elemental analysis, which may also have caused an underestimation of the actual sulfur 
content in the sample. Parallel measurement of the samples' carbon content for 
incorporation in the mass balance would have been required to achieve a more credible 
DS estimation from elemental analysis. Quantitative NMR is essentially independent of 
sample concentration, as the integration is based on the relative intensities of the signals. 
It would therefore be the preferred quantification tool for prospective research, provided 
that the sensitivity can be increased sufficiently and the peaks assigned unambiguously.    
 
Sulfation greatly improved the HGF and OPG binding properties of the alginates when 
compared with the unmodified poly-M and poly-MG samples, and a coherence between 
the estimated sulfation degrees and the relative efficacy of the samples was observed. This 
was most illustratively shown with the relative efficacy of the 2 % S-MG (DS = 0.08) and 
the 5 % S-MG (DS = 1.08) samples, where the latter sample was the more effective in all 
performed protein binding experiments. It is, as mentioned, reasonable to believe that the 
high solubility of the poly-MG alginates resulted in a more homogenous sulfation pattern, 
which may be equally significant as the sulfation degree. The conformation difference 
between poly-M and poly-MG also provides different orientations of the attached sulfate 
groups, which may also affect the binding affinities of the alginates. The molecular weight 
discrepancy between the poly-M and poly-MG samples complicated assessment of the 
impact of flexibility for the protein binding abilities of the different sulfated alginates. The 
longer poly-M chains were expected to exhibit more available binding sites, while the 
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lower molecular weight of the poly-MG chains resulted in a higher sample molarity at the 
given concentrations. Future studies would require a standardization of the sulfation 
conditions as well as the molecular weight of the samples in order to assess the relative 
sample effectiveness with confidence. Nonetheless, sulfation of the alginates resulted in a 
protein binding ability comparable to that of heparin, with a profound increase in 
effectivity compared to the relatively inert unmodified poly-M and poly-M alginates. 
 
The dose-response of OPG binding was not studied; instead a single concentration (3 
µg/ml) of heparin or sulfated alginates was chosen to emphasize the effect of sulfating the 
alginates in comparison to unmodified alginates. The heparin and sulfated alginate 
treatments showed a similar degree of OPG release from the cell surface due to the 
relatively high sample concentrations, which were at the upper limit of the effective dose 
range obtained in the previous HGF experiment. In contrast with the HGF binding 
experiments, the heparin and the most potent sulfated alginates were not able to reach the 
lower MFI value of the positive control, possibly caused by an overall lower affinity of 
the polysaccharides to OPG. Similarly as in the HGF-binding assay, the unmodified poly-
M and poly-MG samples showed no apparent binding to OPG, as they at the same dose 
failed to release a measurable amount of protein from the cell surface. These results 
clearly showed an increase in the OPG protein binding ability of the alginates as a result 
of sulfation. 
 
When studying the induced increase in plasma coagulation time, a drastic difference in the 
effective dose window was seen when comparing heparin and sulfated alginates. This was 
an expected result, considering that the coagulation inhibition in the current assay was 
primarily induced by heparin/antithrombin III-catalyzed inactivation of the supplemented 
factor Xa. The AT-heparin interaction is highly specific and based on the pentasaccharide 
sequence illustrated in Figure 5, which is not found in the sulfated alginates. It was, 
however, observed that the sulfated alginates caused an increase in coagulation time when 
compared with the unmodified poly-M and poly-MG alginates. The attached sulfate 
groups add to the inherent negative charge of the alginate, facilitating stronger 
electrostatic interactions either with factor Xa directly, or indirectly through other plasma 
components. It is not certain whether the interaction has an allosteric effect on the activity 
of the bound protein or if the sulfated alginates inhibit the factors by sequestering them 
from their targets in the coagulation pathway. Also, a relative efficacy difference was 
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observed coherent with the estimated sulfation degrees, although the 5 % S-MG showed a 
profoundly greater effect than any of the other samples. As discussed above, it was 
difficult to assess the relative efficacy of the samples based on sulfation degree 
estimations alone, since there was a disparity in molecular weight between the poly-M and 
poly-MG samples, and as the acidic sulfation reaction was likely to have affected the 
sulfation pattern to a varying extent. The observed high effect of 5 % S-MG may be 
credited to its high estimated DS, higher flexibility and sample molarity, as well as a 
substitution pattern expected to be dissimilar to that of the sulfated poly-M alginates. It is 
still reasonable to assume that the flexibility of the alginate is significant for the properties 
studied. The conformational flexibility of heparin credited to the iduronic acid monomer 
has been postulated to confer important binding properties to the heparin and heparan 
sulfate (Rees, Morris et al. 1985). Similarly, a high conformational flexibility may enable 
alginates to adapt more easily to irregular surfaces and utilize additional binding sites on 
proteins. 
 
Upon repeating the experiment, an irregularity in the recorded coagulation times at high 
treatment concentrations was seen, although the observed relative efficacy of the samples 
remained the same, showing 5 % S-MG as the most effective treatment after heparin. The 
aberrations were assumed to be a result of using different blood plasma donors for the two 
experiments, but could potentially by caused by a decreased sustainability of the plasma, 
treatment or other assay components over time. As the main aberrations were observed at 
higher concentrations, it should also be considered that the reliability of the assay may 
decrease at high treatment concentrations, which to confirm would have required 
additional experiments covering a larger dose range.   
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5 Prospective Research 
 
The sulfated alginates derived in the present study showed a relatively low efficacy in 
terms of protein binding and particularly in prolongation of the coagulation time 
compared to heparin. It was, however, shown that sulfation drastically improved the 
assayed properties of the alginates compared to the unmodified poly-M and poly-MG 
alginates. Creating an alginate-derived heparin analog with equally prominent 
anticoagulating properties may prove difficult due to the absence of a specific AT-
activating sequence. Still, it has been shown that it is possible to obtain the effects of 
heparin caused by non-specific interactions, which may be further optimized by increasing 
the sulfation degree and flexibility. It is possible and may be desirable to achieve a more 
moderate therapeutic effect, preferably also with less adverse effects, through the use of a 
sulfated alginate with a regularity in molecular weight, sequence and modification pattern. 
 
There are improvements to be made with the prospect of more thorough characterization 
of the sulfated alginates through 
13
C NMR analysis. Producing and analyzing a sulfated 
poly-G alginate would be essential for unambiguous assignation of the sulfated poly-MG 
spectrum, as the polyalternating alginate still remains a prime candidate for developing a 
functional heparin analog  due to the high solubility and conformational flexibility. It is 
also desirable to increase the quantitative reliability of the 
13
C NMR analysis, either 
through increasing the 
13
C abundance through incorporation of the isotope during the 
alginate synthesis, or by increasing the recycle delay in the NMR experiments to ensure 
full relaxation. These efforts would also be likely to increase the resolution of the spectra 
and reduce noise, contributing to the processes of correct peak assignation and signal 
integration. 
 
Milder sulfation techniques would contribute to a more predicted response with respect to 
reaction conditions and the resulting sulfation degrees, and may provide a higher DS than 
achieved in the current study. It is also likely to reduce the formation of reaction by-
products, making the purifying process less complicated and time-consuming. A more 
homogenous sulfation pattern would also be expected by reducing the acidity of the 
reaction and thus precipitation of the alginate, which would be a necessity when studying 
the relative impact of sulfation degree and flexibility on the efficacy of the sulfated 
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alginates. Of particular interest is the sulfation technique described by Fan and coworkers, 
involving the use of the sulfating agent (N(SO3Na)3) (Fan, Jiang et al. 2011), which has 
also proven applicable for sulfation of other polysaccharides. The flexibility of the poly-
MG alginate can be further increased prior to sulfation through periodate oxidation, 
resulting in greater solubility and potentially leading to an increased sulfation degree and a 
stronger biological effect. 
 
In further assessment of anticoagulating properties it would be desirable to study the 
activity of the sulfated alginates using several different assays and determe the response 
over an increased dose range, as some aberrations were observed at high concentrations in 
the present study. It is also of interest to eventually create shorter sulfated alginate chains 
and oligomers to assess maximal sulfation degree and study chain length dependency in 
various interactions. Furthermore, the sulfated alginates may be incorporated into alginate 
gel systems to facilitate beneficial interactions, for instance with encapsulated cells or in 
tissue engineering systems using alginate gel matrices. 
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6 Concluding Remarks 
 
Poly-M and poly-MG alginates were successfully sulfated using the sulfating agent 
chlorosulfonic acid in formamide. Covalently attached sulfate groups to the alginate were 
detected using FTIR spectroscopy and confirmed through elemental analysis and 
13
C 
NMR spectroscopy. The more flexible poly-MG alginates showed a higher solubility in 
formamide compared to poly-M, resulting in higher sulfation degrees at lower 
chlorosulfonic acid concentrations, as estimated by elemental analysis. The structures of 
the sulfated alginates were studied using NMR, and a characterization of the novel signals 
was proposed for the sulfated poly-M samples. A secondary estimation of the sulfation 
degrees was also elaborated through integration of the 
13
C spectra. Analysis with SEC-
MALLS showed no pronounced degradation of the alginate as a result of sulfation. A vast 
improvement was seen in the ability of sulfated alginates to bind hepatocyte growth factor 
and osteoprotegerin when compared with unmodified poly-M and poly-MG alginates. 
Sulfation of the alginates also resulted in measurable prolongation of plasma coagulation 
time, although a large increase in dose was required to achieve this effect, compared with 
heparin. Of the tested sulfated alginates, the poly-MG alginate with the highest estimated 
sulfation degree exhibited the highest degree of protein binding and the largest increase in 
plasma coagulation time.  
 
The results showed that alginates can be modified to exhibit biological properties 
analogous to heparin through chemical sulfation, and that the analog can be structurally 
characterized using the techniques described in this thesis. It was also proposed that the 
methods could be further optimized, primarily through standardization of the sulfation 
conditions, to amplify the biological effects achieved and to obtain more confident 
qualitative and quantitative data for the structural characterization of the analog. 
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Appendices 
 
 
A. SEC-MALLS Output Data 
 
The molecular weight averages and distributions of the unmodified and sulfated alginate 
samples were studied using SEC-MALLS. The data for the poly-M and poly-MG samples 
studied are listed in Table A 1 and Table A 2, and the distributions are illustrated in the 
chromatography charts shown in Figure A 1 and Figure A 2, respectively. 
 
Symbols and abbreviations: 
Mn = Molecular number average 
Mw = Molecular weight average 
Rz = Radius of gyration from the angle dependence of light scattering 
dn/dc = Refractive index 
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Table A 1: SEC-MALLS data for unmodified (Poly-M) and sulfated polymannuronic acid (S-M) 
samples.  
 Mn 
(kDa) 
Mw 
(kDa) 
Polydispersity 
(Mw/Mn) 
Rz (nm) Injected 
mass (µg) 
Calculated 
mass (µg) 
dn/dc 
(ml/g) 
Peak limits 
(min) 
Poly-M 23.8 32.1 1.35 27.7 75 5.86E+01 0.15 19.82 - 23.61 
2 % S-M 23.0 30.6 1.33 21.5 150 6.31E+01 0.15 19.98 - 24.41 
5 % S-M 22.1 31.4 1.43 18.7 150 5.57E+01 0.15 20.09 - 25.16 
10 % S-M 24.2 32.6 1.35 18.5 150 6.11E+01 0.15 20.07 - 24.45 
Average 23.3 31.7 1.36 21.6 131.3 5.96E+01 0.15  
Standard 
deviation 
1.4 1.3 0.05 4.8 64.9 4.80E+00 0  
 % Standard 
deviation 
6.2 4.1 3.56 22.4 49.5 8.05E+00 0  
Minimum 22.1 30.6 1.33 18.5 75 5.57E+01 0.15  
Maximum 24.2 32.6 1.43 27.7 150 6.31E+01 0.15  
 
 
 
Figure A 1: Chromatography chart from SEC-MALLS analysis of unmodified (M) and sulfated (S-M) 
polymannuronic acid samples. A refractive index (dn/dc) value of 0.15 was used for all samples. 
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Table A 2: SEC-MALLS data for unmodified (Poly-MG) and sulfated (S-MG) polyalternating 
alginate samples. 
 Mn 
(kDa) 
Mw 
(kDa) 
Polydispersity 
(Mw/Mn) 
Rz 
(nm) 
Injected 
mass (µg) 
Calculated 
mass (µg) 
dn/dc 
(ml/g) 
Peak limits 
(min) 
Poly-MG 11.8 14.3 1.21 12.5 150 1.21E+02 0.15 20.44 - 24.63 
1 % S-MG 12.1 17.0 1.41 15.1 150 6.23E+01 0.15 20.23 - 26.18 
2 % S-MG 12.8 18.4 1.43 15.6 150 6.40E+01 0.15 20.19 - 25.98 
5 % S-MG 15.8 22.9 1.45 17.0 150 4.99E+01 0.15 20.38 - 26.08 
Average 13.2 18.2 1.37 15.1 150 7.42E+01 0.15  
Standard 
deviation 
2.1 5.0 0.19 3.0 0 3.66E+01 0  
 % Standard 
deviation 
15.8 27.3 13.81 20 0 4.94E+01 0  
Minimum 11.8 14.3 1.21 12.5 150 4.99E+01 0.15  
Maximum 15.8 22.9 1.45 17.0 150 1.21E+02 0.15  
 
 
 
Figure A 2: Chromatography chart from SEC-MALLS analysis of unmodified (MG) and sulfated (S-
MG) polyalternating alginate samples. A refractive index (dn/dc) value of 0.15 was used for all 
samples. 
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B. Elemental Analysis Data - Calculation of Degrees of Sulfation 
 
The degrees of sulfation (DS) of the sulfated alginates were estimated through 
measurement of the sulfur contents in the samples using HR-ICP-MS, followed by 
correlation of the data to a standard curve based on theoretical sulfur content of a sulfated 
alginate with set DS values. Standard curve values were derived from a mass balance 
equation including the sulfated alginate monomer as well as associated water molecules 
and counter-ions. 
 
Calculation example of standard curve values: 
 
The referential degree of sulfation x = 2 was inserted into the mass balance equation 2.1 
previously elaborated, and the total monomer mass was calculated as shown below. 
 
Mass = C6O6H5 + (x+1)Na
+
 + xSO3
-
 + H2O 
          = 173.1 g/mol + (2+1)23 g/mol + (2)80 g/mol + 18 g/mol  
          = 420.1 g/mol 
 
The sulfur content in percent was found by dividing the molecular weight of the sulfur by 
the calculated total monomer mass, and is shown in Table B 1 with corresponding DS 
values from 0 to the theoretical maximum of 2. The sulfur content was graphed as a 
function of DS, and a second degree function was fitted to the standard curve, shown in 
Figure B 1. 
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Mass sulfur = 
          
           
       = 15.2 % 
 
Table B 1: Calculated mass and sulfur content of sulfated alginate monomers for standard curve plot. 
DS Mass (g/mol)  %S 
2 420.1 15.2 
1.5 368.6 13.0 
1 317.1 10.1 
0.5 265.6 6.0 
0 214.1 0.0 
 
 
 
Figure B 1: Standard curve of theoretical sulfur content (%) in sulfated alginates as a function of 
degree of sulfation (DS). A second degree function was fitted to the curve with the equation shown in 
the graph. 
 
 
 
 
 
 
y = -2.5029x2 + 12.499x + 0.1296 
0.0 
2.0 
4.0 
6.0 
8.0 
10.0 
12.0 
14.0 
16.0 
0 0.5 1 1.5 2 
S
u
lf
u
r
 c
o
n
te
n
t 
(%
) 
DS 
68 
 
Calculation example of sample DS: 
 
The sulfur content in the 2 % S-M sample was measured at 1.6124 %, which was inserted 
into the standard curve equation shown in Figure B 1. The calculated value for x 
corresponded to the estimated degree of sulfation for the sample, giving in the values 
listed in Table B 2. 
 
 
1.6124 = -2.5029x
2
 + 12.499x + 0.1296  
-2.5029x
2
 + 12.499x - 1.4828 = 0 
           
  
          
  
 
x = 0.1216 
 
Table B 2: Calculated degrees of sulfation (DS) in poly-M and poly-MG alginates sulfated using 
chlorosulfonic acid concentrations of 1 %, 2 %, 5 % and 10 %, based on the sulfur contents of the 
samples measured through HR-ICP-MS, and the derived standard curve equation shown in Figure B 
1. 
Sample S (ug/g)  %S x = DS 
2 % S-M 16 124 1.6124 0.1216 
5 % S-M 91 359 9.1359 0.8732 
10 % S-M 82 222 8.2222 0.7645 
1 % S-MG 10 774 1.0774 0.0770 
2 % S-MG 60 921 6.0921 0.5342 
5 % S-MG 106 993 10.6993 1.0787 
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C. 13C NMR Integration Values 
 
 
The integration values for the poly-M 
13
C NMR spectra shown in Figure 12 of the thesis 
are listed below in Table C 1. Estimations of the degrees of sulfation for the samples were 
made with respect to signals associated with carbons C1 or C2 and C3.   
 
Table C 1: 
13
C NMR integration value for poly-M alginates sulfated using chlorosulfonic acid 
concentrations of 2 %, 5 % and 10 %, with estimation of sulfation degrees shown in bold. Samples 
were dissolved in D2O and the spectra were recorded at 40 
o
C on a 600 MHz spectrometer with an 
inverse gated decoupling scheme, 30
o
 pulse angle and 5 seconds intrascan delay. 
Sample IC2 IC3 IC2S IC3S            
                   
 
IC1 IC1(S+SS)            
               
 
2 % S-M 2.248 1.376 0.595 0.347 0.206 1.000 0.604 0.377 
5 % S-M 3.006 1.887 6.641 4.641 0.697 1.000 7.775 0.886 
10 % S-M 1.979 1.323 1.671 1.792 0.512 1.000 2.194 0.687 
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D.  Flow Cytometry Data 
 
Myeloma RPMI cells with bound HGF or OPG were treated with heparin and sulfated 
alginates, and subsequently labeled with fluorescent antibodies (FITC). Flow cytometry 
was utilized to measure the fluorescence of the cells, corresponding to the amount of 
remaining bound proteins. The mean fluorescence intensity (MFI), defined as the mean 
area of the cell count distribution as a function of fluorescing FITC measured (Figure D 
1), was recorded for a selected viable cell population. 
 
 
Figure D 1: Analysis of flow cytometry data using FlowJo. Recording of mean fluorescein 
isothiocyanate (FITC) area for myeloma RPMI cells with bound HGF. (A) Negative control sample 
labeled with HGF 2B5 primary antibody and GAM FITC secondary antibody. (B) Isotype control 
sample labeled with non-HGF binding Mouse IgG1 pure primary antibody and GAM FITC secondary 
antibody. 
 
Figure D 2 shows the measured MFI of HGF-stimulated myeloma RPMI cells treated with 
a single concentration of heparin or the sulfated alginate samples in reference to an 
untreated negative control and a positive isotype control. The four most potent sulfated 
alginate samples (5 % S-M, 10 % S-M, 2 % S-MG and 5 % S-MG) were selected for 
further study.  
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Figure D 2: Measured mean fluorescence intensity from antibody-labeled HGF proteins bound to 
myeloma RPMI cell surface, following treatment with 10 µg/ml heparin or poly-M and poly-MG 
alginates sulfated using 1 %, 2 %, 5 % or 10 % chlorosulfonic acid. 
 
A dose-response curve was established using heparin and the selected sulfated alginate 
samples in relation to a positive isotype control, a negative untreated control and 
unmodified poly-M and poly-MG alginates. The recorded MFI values are listed below in 
Table D 1 and graphed in Figure D 3 with guidance lines for the proposed dose-response 
curve. 
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Table D 1: Mean fluorescence intensity (MFI) values from flow cytometry of HGF-stimulated cells treated 
with heparin or poly-M and poly-MG alginates either unmodified or sulfated using chlorosulfonic acid 
concentrations of 2 %, 5 % or 10 %, and labeled with fluorescein isothiocyanate (FITC) antibody. S-M 
and S-MG data were collected from separate experiments. 
 MFI 
Concentration 
(µg/ml) 
Heparin 5 % S-M 10 % S-M 2 % S-MG 5 % S-MG 
10 224 219 216 210 205 
3 204 243 239 292 213 
1 223 351 440 697 258 
0.3 365 717 790 1515 568 
0.1 836 1472 1740 1999 1500 
0.01 1773 1927 1827 1987 2116 
0.001 1908 1932 1476 2013 1654 
  Isotype 
Control 
Untreated Poly-M  
(10 µg/ml) 
Poly-MG  
(10 µg/ml) 
  207 1798 1933 1765 
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Figure D 3: Measured mean fluorescent intensity (MFI) from FITC Ab-labeled HGF proteins bound 
to myeloma RPMI cell surface, following treatment with heparin or poly-M and poly-MG alginates 
sulfated using 2 %, 5 % or 10 % chlorosulfonic acid. as a function of treatment concentration. S-M 
and S-MG data were collected from separate experiments. 
 
The percentage of cell-bound HGF was estimated by dividing the MFI values of the 
heparin or sulfated alginate samples (Table D 1) by the value of the untreated negative 
control set to 100 %, and is shown below in Table D 2.  
 
Table D 2: Calculated percentage of cell-bound HGF following treatment with heparin or sulfated 
alginates. Mean fluorescence intensities were recorded by flow cytometry and converted to % cell-
bound OPG in reference to the untreated control sample. S-M and S-MG data were collected from 
separate experiments. 
 Cell-bound HGF (%) 
Concentration 
(µg/ml) 
Heparin 5 % S-M 10 % S-M 2 % S-MG 5 % S-MG 
10 12.5 12.2 12.0 11.7 11.4 
3 11.3 13.5 13.3 16.2 11.8 
1 12.4 19.5 24.5 38.8 14.3 
0.3 20.3 39.9 43.9 84.3 31.6 
0.1 46.5 81.9 96.8 111.2 83.4 
0.01 98.6 107.2 101.6 110.5 117.7 
0.001 106.1 107.5 82.1 112.0 92.0 
0 100.0 100.0 100.0 100.0 100.0 
 Untreated  Poly-M 
(10 µg/ml) 
 Poly-MG 
(10 µg/ml) 
 100  107.5  98.9 
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In a separate experiment, myeloma RPMI cells were stimulated with the protein 
osteoprotegerin (OPG) before treating with a single concentration (3 µg/ml) of heparin or 
unmodified and sulfated alginates. The cell-bound protein was subsequently labeled with 
a primary OPG antibody and a secondary fluorescent (FITC) antibodies as previously 
described, and the fluorescence was measured using flow cytometry. MFI values were 
converted to cell bound HGF (%) in reference to the untreated negative control set to 100 
%, with values listed in Table D 3. 
 
Table D 3: Mean fluorescence intensity (MFI) values from flow cytometry of osteoprotegerin (OPG)-
stimulated cells treated with 3 µg/ml heparin or poly-M and poly-MG alginates either unmodified or 
sulfated using chlorosulfonic acid concentrations of 2 %, 5 % or 10 %, and labeled with fluorescein 
isothiocyanate (FITC) antibody. MFI values were converted to cell-bound OPG in reference to the 
untreated control sample set to 100 % cell-bound OPG.  
Control samples MFI Cell-bound OPG (%) 
Untreated 920 100.0 
Isotype control 156 17.0 
Treatments (3 µg/ml)   
Poly-M 971 105.5 
Poly-MG 1074 116.7 
Heparin 304 33.0 
5 % S-M 253 27.5 
10 % S-M 244 26.5 
2 % S-MG 258 28.0 
5 % S-MG 269 29.2 
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E. Coagulation Time Measurements 
 
The recorded plasma coagulation times for the sulfated alginate samples are listed in 
Table E 1, including the coagulation times for unmodified poly-M and poly-MG alginates, 
measured at the two highest concentrations in the selected dose range. Times were 
recorded from added RECALMIX, as described in the HEPTEST® protocol, to visible 
solidification of the plasma. 
 
Table E 1: Recorded coagulation times (s) of normal human plasma supplemented with factor Xa and 
treated with poly-M and poly-MG alginates either unmodified or sulfated using chlorosulfonic acid 
concentrations of 2 %, 5 % and 10 %.  
 Coagulation time (s) 
Concentration 
(µg/ml) 
Poly-M Poly-MG 5 % S-M 10 % S-M 2 % S-MG 5 % S-MG 
0   21 21 21 21 
7.0   27 24 22 24 
13.9   29 26 25 30 
27.8   34 34 29 42 
55.6 21 23 43 52 35 78 
111.2 20 24 72 81 37 227 
 
 
The plasma coagulation times of the heparin-treated samples are listed in Table E 2.  
 
Table E 2: Recorded coagulation times (s) of normal human plasma supplemented with factor Xa and 
treated with increasing concentrations of heparin. 
 Coagulation time (s) 
Concentration 
(µg/ml) 
Heparin 
0 21 
1.7 32 
3.4 56 
7.0 132 
13.9 513 
 
 
